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Abstract and Key Words
Previous work done by the Kerr group has shown that tetrahydro-1,2-oxazines can be
efficiently synthesized using a three component coupling reaction between a hydroxylamine,
aldehyde and cyclopropane diester. This affords the desired heterocycle efficiently with a
wide variety of substitution. When one esters bears an allyl group a Tsuji
dehydrocarbonylation reaction may take place resulting in the formation of a 4,5-dihydro1,2-oxazine. This motif contains a vinylogously acidic proton which is extremely labile and
easily deprotonated. Under basic conditions this proton is removed and consequently the N-O
bond is cleaved and subsequent condensation occurs forming a pyrrole. Using a sequence of
chemical transformations specific pyrroles generated from the above methodology could be
transformed into either BM 212 an anti-tuberculosis drug or Atorvastatin Calcium an anticholesterol drug. Each pharmaceutical will be derived using a three component coupling
reaction and then conversion to a pyrrole followed by manipulations of the resulting
functional groups.
Keywords: Cyclopropanes, nitrones, tetrahydro-1,2-oxazines, 4,5-dihydro-1,2-oxazines,
pyrroles, BM 212, Atorvastatin Calcium, Pd catalyzed, dehydrocarbonylation
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1 Introduction Donor Acceptor Cyclopropanes and Pyrroles
1.1 Donor Acceptor Cyclopropanes
1.1.1 Structure and Bonding in Cylopropanes
Since the first synthesis of the cyclopropane ring in 1881 by Freund, who treated 1,3dibromopropane with sodium to form the ring (Scheme 1.1), the characteristic three
membered ring has become an unparalleled synthetic tool and has been a subject of
interest to many synthetic organic chemists for a number of years.1

Scheme 1.1 Freund's cyclopropane synthesis
The strained carbocycle displays reactivity comparable to that of olefins. Reactions with
a large variety of nucleophiles, electrophiles and radical species are well known to the
scientific community.2
The cyclopropane motif has unique physical and chemical properties that significantly
differ from that of other alkanes and cycloalkanes. From a physical perspective the
concept of an sp3 hybridized carbon atom in a cyclopropane ring is unheard of. A typical
saturated alkane contains sp3 carbon atoms with tetrahedral bond geometries and bond
angles of approximately 109.5°.1 The carbon atoms in a cyclopropane ring make up what
is considered an equilateral triangle. Therefore the resulting interior bond angles must be
approximately 60°. There is a 49.5° deviation in bond angle from that of a saturated
alkane. The acuteness of the bond angle imparts a significant amount of ring strain onto
the cyclopropane.2 In order to alleviate the angle strain present each cyclopropane, which
traditionally appears sp3 hybridized, adopts more p character in the bonds that make up
the ring to convey some flexibility.1 As a direct result the external bonds must contain
more s character. This renders the C-C bonds within the ring shorter than that of normal
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alkanes. The current most accepted model for the bonding within a cyclopropane is the
Forster-Coulson-Moffit model seen in Figure 1.1.1

Figure 1.1 Orbital structure of a cyclopropane according to the Forster-CoulsonMoffit model
In this mode of bonding, overlap of the C-C bonding orbitals is not along the axis of the
bond but off centered resulting in less effective bent bonds. The weaker bonds give rise to
the unique reactivity observed with the cyclopropane ring.1

1.1.2 Donor Acceptor Cyclopropanes
Activated cyclopropanes have proven to be versatile building blocks in organic synthesis.
Their versatility arises from the ability to impart functionality into existing frameworks,
allowing for the formation of a multitude of cyclic systems and perhaps most importantly
the generation of carbon-carbon bonds. There are three main types of activated
cyclopropanes:3
I.
II.
III.

Acceptor cylcopropanes
Donor cyclopropanes
Donor acceptor cyclopropanes

Acceptor cyclopropanes contain functional groups that are electron withdrawing in nature
and are capable of stabilizing additional electron density. Donor groups are the exact
opposite they provide additional electron density, in turn making the cyclopropane more
nucleophilic in character. Figure 1.2 shows general modes of reactivity for acceptor and
donor cyclopropanes.4
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Figure 1.2 Modes of reactivity of substituted cylcopropanes
The final class, donor acceptor cyclopropanes contain both orthogonal functional groups
and can be further divided into two subcategories; geminal and vicinal. Geminal DA
systems have the orthogonal substituents on the same carbon whereas in a vicinal system
they are on adjacent carbons (Figure 1.3).3 Vicinal DA cyclopropanes have proven to be
much more useful due to the substitution pattern. The substituents can act synergistically
in an electron push pull relationship.4 This electron flow makes the cyclopropane react
similarly to a 1,3-dipole. Figure 1.3 shows the two types of DA cyclopropanes and the
general mode of reactivity for vicinal DA systems under Lewis acidic conditions.
A

D A
D
Geminal Substitution

Vicinal Substitution

A

R
Lewis Acid

D

D

A

R

Figure 1.3 DA cyclopropanes
As seen in Figure 1.3, under Lewis Acidic conditions vicinal DA cyclopropane can act as
a 1,3 dipole synthon in homo Michael reactions. This mode of reactivity can be exploited
to form a variety of heterocyclic systems.4 Pyrrolidines, tetrahydropyrans and tetrahydro1,2-oxazines are just a few cyclic systems attainable with DA cyclopropanes.
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1.1.3 Synthesis of DA Cyclopropanes
1.1.3.1 Rhodium and Copper Catalyzed Cyclopropanation
There currently exists an immense number of ways to synthesize cyclopropanes.
Arguably the most common method is through the addition of a carbene or some
equivalent to an alkene. This method of cyclopropanation was initially described by
Silberrad and Roy in 1906, however it was not until many years later that the true impact
of this process was realized. By the 1960's this method was being readily employed to
synthesize cyclopropanes.5 Various transition metals had been screened; copper and
rhodium catalysts had emerged as the most efficient metals of choice.

With the

combination of a substituted carbenoid and an olefin a formal [2+1] cycloaddition can
occur forming substituted cyclopropanes. Scheme 1.2 shows a select few reactions
employing metal carbene complexes to synthesize DA cyclopropanes.3,6

Scheme 1.2 Cyclopropanation through the use of a carbene
Whether a diazoalkane or iodonium ylide was used, both decompose readily in the
presence of metal catalysts to afford carbenoids capable of undergoing clean addition to
olefins. In general catalyst turnover is very high for cyclopropanation reactions requiring
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only up to 3 mol % in the worst of circumstances.5 More electron rich olefins react faster
than electron deficient olefins; which in some cases fail to react at all. Electron deficient
olefins have the tendency to form pyrazolines instead of undergoing the desired
cyclopropanation reaction. Barring steric factors cis olefins react slightly faster than trans
olefins.5 In cases where multiple double bonds are present the catalysts show
regioselectivity towards the more electron rich olefins.
This methodology has been extensively employed in laboratory scale synthesis as well as
industrial processes. It continues to be an area of interest for many researchers and more
recently significant discoveries have been made towards chiral catalysis (Scheme 1.3).3

Scheme 1.3 Asymmetric cyclopropanations
The size of the group attached to the diazo component has a minor influence on the
enantioselectivity of the cyclopropanation, but greatly effects the cis/trans selectivity.
Asymmetric cyclopropanation of simple olefins has been achieved with high selectivity
however a significant amount still needs to be investigated to mimic these selectivities
with more complicated olefins. Currently to date the carbenoid mediated [2+1]
cycloaddition is the most commonly used method to synthesize DA cyclopropanes.5

1.1.3.2 Simmons-Smith Cyclopropanation
Moving from one transition metal catalyzed cyclopropanation to another, the SimmonsSmith cyclopropanation utilizes CH2I2 in the presence of a zinc copper amalgam to
stereospecifically convert unfunctionalized alkenes into cyclopropanes. The two
discovered the reaction in 1958 while working at DuPont chemicals.7 The Simmons-
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Smith cyclopropanation is a concerted process proceeding through a butterfly like
transition state. A slight modification by Furukawa in 1966 is now the more commonly
used method; instead of having to work with the complicated Zn-Cu system it is replaced
with diethyl zinc.7 The general Simmons-Smith reaction and some applications can be
seen in Scheme 1.4.7,8,9
Simmons-Smith

R1

Zn-Cu
CH2I2

R1

R

Et2O

R

1-16

R1

Zn-Cu
CH2I2

R1

Et2O

R

R

1-17

1-18

1-19

Furukawa Modification

R1

R3

R

R2

R4

ZnEt2
R4CHI2
Et2O

1-20

R1
R

R3
R2
1-21

Applications

O

O

Zn-Cu
CH2I2

O

O

Et2O, 35 °C
1-22

1-23
O H

O
ZnEt2
CH2I2

O
RO

H
O
1-24

benzene

H

O
RO

H
O
1-25

Scheme 1.4 Applications of the Simmons-Smith cyclopropanation
The Simmons-Smith accepts a wide range of alkenes, ranging from isolated alkenes to α,
β unsaturated ketones and aldehydes. As was the case for the Rh and Cu catalyzed
cyclopropanations more electron rich olefins react faster than that of electron deficient
ones. One could use this kinetic resolution to selectively cyclopropanate one olefin over
another.
When cyclopropanating diastereomers the reagent always approaches from the less
hindered face of the alkene. Asymmetric Simmons-Smith reactions are carried out
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similarly to Rh and Cu cyclopropanations; through the use of some chiral ligand or
auxillary a cyclopropane ring with the desired stereochemistry can be formed.7 One such
example of an asymmetric Simmons-Smith reaction can be seen in Scheme 1.5. A slight
modification of the original reaction was used to carry out an asymmetric
cyclopropanation en route to the total synthesis of (+)-Ambruticin.10
OH
R

CH3CHI2
Et2Zn
DCM, DCE

OH
R

(R,R)-dioxaborolane,
-10°C, 2 h
1-26

1-27

Scheme 1.5 Asymmetric Simmons-Smith

1.1.3.3 Corey-Chaykovsky Cyclopropanation
The final cyclopropanation reaction that will be discussed is the Corey-Chaykovsky
cyclopropanation. Developed by Corey and Chaykovsky in 1962, they discovered that
deprotonation of a trimethylsulfonium halide under an atmosphere of nitrogen at room
temperature would generate a stable dimethylsulfonium methylide.11 If an α,β unsaturated
carbonyl is treated with the dimethylsulfonium methylide reagent a conjugate addition
takes place producing a cyclopropane. Scheme 1.6 shows the general Corey-Chaykovsky
reaction followed by applications of the reaction.11,12
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Scheme 1.6 Corey-Chaykovsky cyclopropanation
This reaction is more significant to the work described here because almost all
cyclopropanes used were synthesized using the Corey-Chakovsky reaction. It is the
method of choice because the reagents are all inexpensive and the reaction itself can be
carried out successfully and in high yields on large scales.

1.1.4 Applications of Donor Acceptor Cyclopropanes
As previously mentioned DA cyclopropanes are extremely useful to synthetic chemists.
They have the ability to make a variety of heterocycles which can then be applied to the
total synthesis of many natural products. Cyclopropanes can react with a wide array of
dipolar reagent in annulation reactions to make a variety of heterocycles. Two examples
of cyclopropane cycloadditions that were applied to the total synthesis of two natural
products can be seen in Scheme 1.7.13,14 Both of these complex molecules were
synthesized in the Kerr lab by Avedis Karadeolian and Cheryl Carson respectively.

9

Scheme 1.7 Reactions of cyclopropanes
Through the use of cyclopropanes both istatisine A and (+)-phyllantidine were
synthesized in 14 and 12 steps respectively with overall yields of 5.8 % and 6 %.
Four other equally as significant cycloadditions with DA cyclopropanes can be seen in
Scheme 1.8. All of the annulations pictured below were developed by the Kerr group.
Each reaction can support a wide range of substrates and provides the cyclic systems
rapidly and efficiently.15
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Scheme 1.8 Cycloadditions with cyclopropanes
As you can see from all the examples presented here DA cyclopropanes provide a broad
spectrum of utility. They can be applied in almost every aspect of total synthesis but their
greatest use is dipolar cycloaddition reactions. These reactions can allow for the
formation of large libraries of biologically active heterocycles or for direct application
towards the complicated and unique frameworks found in natural products. There is no
doubt that cyclopropanes will continue to be a widespread reagent in organic synthesis.

1.2 Pyrroles
1.2.1 History of Pyrrole
The pyrrole moiety is a remarkable compound since its discovery this heterocyclic
system has been continuously found in nature at the very heart of many different
compounds necessary for survival of living organisms. Pyrrole was first surmised in 1834
by Runge when he observed that coal tar and bone oil contain a substance that dyes pine
splinters red. Runge called this unidentified substance pyrrole, meaning fiery oil.
Although he did not actually isolate the compound he is still considered the original
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discoverer of pyrrole. It was in fact not isolated until 23 years later in 1857 when a
scientist named Anderson converted the compound to its potassium salt. The actual
structural formula was established in 1870 (Figure 1.4).16

Figure 1.4 Structure of the pyrrole
Pyrrole is a colourless compound, is susceptible to air oxidation and readily polymerizes
under acidic conditions. Pyrroles are five membered aromatic systems with the lone pair
on nitrogen delocalized through the ring. This gives the ring a total of six π electrons
fulfilling Huckel’s rules for aromaticity. As such the pyrrole ring displays reactivity
identical to that of an aromatic molecule.16
The N-C1,5 and C3-C4 bond lengths are shorter than that of normal single bonds and the
C1-C2 double bond is longer than that of a normal C-C double bond.17 The delocalization
of the lone pair on nitrogen greatly decreases the overall basicity of nitrogen; giving
pyrrole a negligible basicity compared to that of a secondary amine. The ring system is
considered more electron rich than benzene, as such nucleophilic aromatic substitution is
relatively unheard of with the pyrrole ring. However it has been documented with
protonated forms of the ring.16 Pyrrole undergoes electrophilic aromatic substitution
faster than that of benzene and substitution occurs preferentially at the two positions. This
is due to the fact that a cationic intermediate at the 3 position has increased resonance
stability than a cation at the two position (Figure 1.5).16
H
N

H
N

H

H
N

H

H

H
N

H
N
H

H

Figure 1.5 Resonance structures of the two possible cationic intermediates during
electrophilic aromatic substitution
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1.2.2 Synthesis of Pyrroles
Most pyrrole syntheses are dominated not in the interest of developing new
methodologies but for the synthesis of pyrroles with specific substitution patterns. This
target oriented synthesis is a direct result of the commercial success that pharmaceuticals
containing a pyrrole motif have shown. There currently exists a vast number of resources,
whether it be textbooks or extensive reviews on the synthesis of various forms of the
pyrrole ring.
The wide distribution of the pyrrole in nature is indicative of the ease of which the
pyrrole ring is formed. This can be attributed to the favourable entropy change for five
membered ring formation and the resulting resonance stability of the ring. Due to the
extensive number of pyrrole syntheses the next subsections herein will report a few more
relevant syntheses.

1.2.2.1Paal-Knorr Pyrrole Synthesis
Perhaps the most famous pyrrole synthesis is the Paal-Knorr synthesis developed over
one hundred years ago. The classic Paal-Knorr pyrrole synthesis is an acid catalyzed
condensation of a primary amine with a 1,4-dicarbonyl compound (Scheme 1.9).18
Because of the simplicity and availability of 1,4-dicarbonyl compounds the Paal-Knorr
pyrrole synthesis is the most commonly used method to prepare substituted pyrroles.

Scheme 1.9 Paal-Knorr pyrrole synthesis
The Paal-Knorr reaction works on almost any masked or unmasked 1,4-dicarbonyl
compound and allows the generation of fully substituted pyrroles. Acetic acid has been
most commonly used acid to promote the reaction however TiCl4 has proven effective for
more sterically encumbered substrates. The reaction has been much less successful for
1,4-dialdehydes than 1,4-diketones because of their instability. Finally almost any type of
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amine is accepted, whether it be electron rich, poor, aryl or ammonia.18 The Paal-Knorr
pyrrole sythesis continues to be the most used procedure to generate pyrrole rings.

1.2.2.2 Knorr Pyrrole Synthesis
Developed just two years after the Paal-Knorr reaction, Knorr himself discovered that the
combination of an α-amino ketone with another ketone under thermal and acidic
conditions would afford a tetra-substituted N-H pyrrole (Scheme 1.10).19

Scheme 1.10 Knorr pyrrole synthesis
The reaction itself has been successful under both basic and acidic conditions. The αamino ketones have the tendency to self condensate so they are generally formed in-situ
from the corresponding nitro compounds. α nitrogenation can be easily performed using
HNO2 in the presence of acid; this allows for the generation of almost any α-amino
ketone. N-substituted pyrroles can be synthesized from the corresponding secondary αamino ketones producing fully substituted systems as in the Paal-Knorr reaction.19 When
non symmetrical ketones are used the reaction regioselectively prefers the larger
substituent (R3) to be at C4 in the ring. Mechanistically the reaction proceeds first by
condensation of the amine onto the ketone forming the corresponding imine. Next
tautomerization affords the enamine which can then cyclize via nucleophilic attack onto
the α-ketone. Finally the loss of water and a final tautomerization affords the pyrrole
(Figure 1.6).19
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Figure 1.6 Mechansim of the Knorr pyrrole synthesis

1.2.2.3 Pyrroles from Donor Acceptor Cyclopropanes
In 2003, Yu et. Al. developed a synthesis of di-, tri- and tetrasubstituted N-H pyrroles
through the combination of DA cyclopropanes and α, β-unsaturated nitriles.20 Upon
mixing the two components in the presence of a Lewis acid at low temperatures a cascade
[3+2] dipolar cycloaddition, dehydration and tautomerization sequence ensued affording
pyrroles in moderate to excellent yields (Scheme 1.11).20

Scheme 1.11 Pyrroles from DA cyclopropanes and nitriles
The reaction proved to be most successful when conducted in nitromethane with
TMSOTf as the Lewis acid catalyst. Overall the pyrrole formation was extremely
successful continuously providing yields between 70-90 %.20 The cycloaddition was
shown to be effective with pyran and furan derived cyclopropanes. The diverse
substitution permutations that are possible with this methodology enhance its significance
one hundred fold. The domino reaction allows for precise control over the installation of
substituents at three different positions with a fourth containing an ester which can easily
be manipulated in a variety of different ways. It also demonstrated another one of the
very many uses of DA cyclopropanes.
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1.2.2.4 Nitroso Diels Alder Reactions Producing Pyrroles
Nitroso compounds have shown potent activity in hetero Diels Alder reactions. The [4+2]
cycloaddition reaction that occurs between nitroso compounds and dienes provides quick
access to 4,5-dihydro-1,2-oxazines which have been previously shown to undergo a
reductive N-O bond cleavage and recyclize to form pyrroles on silica gel. In 2005 a
thorough investigation was conducted to determine the range of dienes viable for this
reaction (Scheme 1.12).21

Scheme 1.12 Pyrroles from a nitroso Diels-Alder reaction
The approach used was a three step method to synthesize pyrroles. First a nitroso DielsAlder was conducted affording the 4,5-Dihydro-1,2-oxazines.21 Next a reductive cleavage
of the N-O bond and subsequent oxidation to the ketone resulted in spontaneous
condensation providing pyrrole in a total of three steps. Unfortunately due to the linear
nature of this sequence the overall yields of the pyrroles were relatively low. The DielsAlder reaction could be performed in modest to high yields 51-97 % with the occasional
low yielding substrate. Ring cleavage and condensation consistently resulted in yields
around 75 % for each step. This provided the pyrroles in overall yields between 29-54
%.21 The utility of this chemistry is more greatly emphasized in the substrate scope.
Through this methodology you can generate N protected, tetra-substituted pyrroles
through a mild and simple sequence.

1.2.3 Importance of Pyrroles
Since its discovery the pyrrole motif has been continuously found in nature. It has been a
commonly used heterocycle in the synthesis of many different materials ranging from
drugs to polymers to various dyes. The importance of this small ring system is unmatched
by any other heterocycle.16
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In biological systems the pyrrole ring can be found as a tetramer in two compounds
necessary for all life on Earth, heme and chlorophyll (Figure 1.7). The structural
backbone of both of these compounds is the porphyrin ring, a supramolecular compound
consisting of four pyrrole units connected by a carbon spacer. In respiratory systems
heme is what gives blood its red colour and is responsible for binding oxygen and
transporting it throughout the body. Chlorophyll on the other hand takes part in
photosynthesis and without it plant life would not be capable of using light energy to
convert CO2 into sugar.22

Figure 1.7 Structure of heme and chlorophyll a
Many reviews have been provided which show the appearance and synthesis of many
natural products containing pyrroles.23 All of these natural products show significant
biological activity. For example mitosene a natural product isolated from Streptomyces
caepsitosus has shown potent anticancer activity. Rebek reported the total synthesis of
mitosene forming the penta-substituted pyrrole core via Huisgen chemistry (Scheme
1.13).23

17

Scheme 1.13 Synthesis of penta-substituted pyrrole core of mitosene
These are not even a small fraction of the total number of natural products containing
pyrroles. In fact there are far too many to even attempt making a comprehensive
catalogue of all the natural products with the pyrrole motif. These examples are being
used only to illustrate the importance of the pyrrole ring to life and science.
As far as drugs are concerned, as was the case with natural products there again are far
too many to provide a comprehensive list. As such only a few examples will be given
here. The first two are the anti-cholesterol drug Atorvastatin Calcium (Lipitor®) and the
anti-tuberculosis drug BM 212. Their structures, modes of action and synthesis will be
described in greater detail in the introduction to Chapter 3. For now it is important to
simply point out that both compounds contain the pyrrole ring and are extremely
successful at combating their specific targets. Atorvastatin Calcium has proven to be
unmatched by any other synthetic drugs at targeting cholesterol synthesizing enzymes in
the body. BM 212 has shown more potent activity than the drugs commonly used to
combat tuberculosis.24 The discovery of BM 212 resulted in the creation of an entire class
of pyrrole containing drugs targeting tuberculosis.25
The final drug to be mentioned here is Aloracetam; a nootropic drug used for the
treatment of Alzheimer's disease. The drug itself is a tetra-substituted pyrrole ring
containing a pendant amide. It is readily synthesized from mono-acetylated
ethylenediamine and hexane-2,5-dione. The commercial synthesis can be seen in Scheme
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1.14. The drug is made in two steps, the first being a Paal-Knorr reaction between the two
aforementioned starting materials and the second a Vilsmeier-Haack formylation
reaction.26

Scheme 1.14 Commerical synthesis of Aloracetam

1.3 Description of Thesis
The work described in this report will be split into two separate chapters. The first will
encompass the synthesis of different 1-allyl-1-methylcyclopropane-1,1-dicarboxylates.
The use of these cyclopropanes for the formation of a new type of tetrahydro-1,2oxazines via a three component coupling reaction. Then the one pot conversion of the
tetrahydro-1,2-oxazines into pyrroles using a Pd catalyzed dehydrocarbonylation reaction
followed by N-O bond cleavage and subsequent condensation forming the pyrrole ring
(Scheme 1.15).

Scheme 1.15 One pot conversion of tetrahydro-1,2-oxazines into pyrroles
The second chapter will report the direct application of this methodology towards the
total synthesis of both BM 212 and Lipitor® (Figure 1.8).
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Figure 1.8 Application of the methodology to the total synthesis of BM 212 and
Lipitor®
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2 Synthesis

of

Tetrahydro-1,2-oxazines

and

their

Conversion to Pyrroles
2.1 Introduction
The 1,3 dipole reactivity of a cyclopropane diester can be utilized to efficiently form the
tetrahydro-1,2-oxazine heterocycle. This unique ring system was synthesized by the Kerr
group in 2004, by utilizing a [3+3] cycloaddition between a nitrone and a cyclopropane.1
Later that year the Kerr group refined their work and found an effective way to generate
the nitrone in-situ prior to the addition of the cyclopropane diester (Scheme 2.1).2 This
new method allowed for a larger substrate scope because it was no longer limited by the
availability of nitrones.

Scheme 2.1 Formation of tetrahydro-1,2-oxazines via the three component coupling
reaction
This heterocyclic system itself is scarcely found in nature as such preparations of this ring
system are not abundant.3 It does however appear in several medicinally active natural
products such as FR-900482 and FR-66979 (Figure 2.1).2 Both compounds have shown
potent anti-tumor and antibiotic activity. As such many structural analogues with the
tetrahydro-1,2-oxazine motif have been synthesized.

Figure 2.1 FR900482 and FR66979
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This methodology allows access to a large library of compounds with potential
pharmaceutical activity. The one drawback to the synthesis however is the lack of
functionality at the five position. There does exist a unique reaction that provides the
ability to overcome this issue. In 1982 Tsuji, reported the formation of an α, β
unsaturated ketone from a β-keto allyl ester (Scheme 2.2).4

Scheme 2.2 Tsuji’s Pd catalyzed dehydrocarbonylation
This transformation involved the use of a Pd0 catalyst resulting in the substrate
undergoing a tandem decarbonylation and dehydrogenation reaction forming an α, β
unsaturated ketone. If one of the geminal diesters possessed an allyl group on the
tetrahydro-1,2-oxazine ring the above transformation could be utilized to synthesize 4,5Dihydro-1,2-oxazines (Scheme 2.3)

Scheme 2.3 Conversion to 4,5-dihydro-1,2-oxazines
This reaction would provide a functional handle for subsequent transformations involving
the five position or the newly formed vinylogously acidic proton at the six position. The
proposed catalytic cycle for this reaction can be seen in Figure 2.2.4
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Figure 2.2 Catalytic cycle for the dehydrocarbonylation
The catalytic cycle initiates with the coordination of Pd0 to the terminal olefin. Next an
oxidative addition of the allyl substituent and the carboxylate group to the Pd centre
occurs. This forms a π-allyl complex which quickly decarboxylates to eliminate CO2 and
then rearranges placing the Pd centre alpha to the carbonyl. This allows for a β-hydride
elimination generating an α,β-unsaturated carbonyl and finally the Pd0 catalyst is
regenerated by the reductive elimination of propylene.
These dihydro-1,2-oxazines have the potential to undergo a variety of new
transformations. A few selected transformations that are possible with the new
functionality can been seen in Figure 2.3.5

25

Figure 2.3 Possible transformations of 4,5-Dihydro-1,2-oxazines
The work encompassed in this chapter will entail the synthesis of a new type of
tetrahydro-1,2-oxazine bearing an allyl group on one of the geminal diesters. As well as
the conversion of these tetrahydro-1,2-oxazines into dihydro-1,2-oxazines and the
exploration subsequent transformations with the internal α, β unsaturated ester.

2.2 Results and Discussion
2.2.1 Synthesis

of

Substituted

1-allyl-1methylcyclopropane-1,1-

dicarboxylates
In order to utilize Tsuji’s reaction a 1-allyl-1-methylcyclopropane-1,1-dicarboxylate was
required. Therefore the first task necessary was the mono trans-esterification of the
corresponding 1,1-dimethylcyclopropane-1,1-dicarboxylates as seen in Scheme 2.4.6
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Scheme 2.4 Selective trans esterification of cyclopropane diesters
Deuterium labeling experiments have shown that the rate of saponification of the transester is significantly faster than that of the cis.6 Therefore mono saponifcation is easily
achieved without converting to the diacid. From here deprotonation of the acid with
K2CO3 followed by an SN2 or SN2' displacement of bromine in allyl bromide by the
carboxylate anion affords the required 1-allyl-1-methylcyclopropane-1,1-dicarboxylate.
Figure 2.4 shows the various cyclopropanes manipulated in this study, of which 2-10c-e
was used exclusively by other colleagues.

Figure 2.4 Various Cyclopropanes Used

2.2.2 Synthesis of Allylated Tetrahydro-1,2-Oxazines
With the desired cyclopropanes in hand the tetrahydro-1,2-oxazines were formed
according to the previously reported procedure.2 Using either a three component coupling
reaction or by directly reacting a nitrone with a cyclopropane this heterocyclic motif can
be accessed. Both methods are carried out under an inert atmosphere of Ar in the
presence of 4 Å MS with 10 mol % of a Lewis acid catalyst; either Yb(OTf)3 or
Sc(OTf)3, in toluene or DCM. The choice between a two or three component method was
based on the preference of the chemist and availability of material. In this instance if
some of the necessary nitrone was in our personal stock a two component method was
used; otherwise a three component was chosen. Both methods afforded the tetrahydro-
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1,2-oxazines in excellent yields ranging from 84-96%. The tetrahydro-1,2-oxazines were
formed in various diastereomeric ratios at the geminal diester carbon (C4). Table 2.1
shows

the

various

tetrahydro-1,2-oxazines

synthesized

with

the

1-allyl-1-

methylcyclopropane-1,1-dicarboxylates

Table 2.1 Various tetrahydro-1,2-oxazines synthesized from either a two or three
component coupling reaction

a

R1

R2

R3

Yield (%)

Compound

Ph

Ph

Ph

91

2-7a

Ph

Ph

(E)-styryl

89

2-7b

Ph

Ph

2-furyl

93

2-7c

Ph

Ph

i-Pr

85

2-7d

Ph

Ph

4-O2N-C6H4-

94

2-7ea

Ph

Tol

4-MeO-C6H4-

96

2-7fa

Et

Ph

Ph

84

2-7gb

Et

Ph

2-furyl

89

2-7hb

Formed via the direct reaction of a nitrone with a cyclopropane. b 10 mol % Sc(OTf)3 used.

According to the previously determined mechanism each tetrahydro-1,2-oxazine is
formed with a cis relationship between the substituents on carbons three and six.7 2-10b
required a much more reactive Lewis acid in order to obtain exceptional yields. Initial
studies with Yb(OTf)3 resulted in lower yields, less than 50%, and sometimes even with
heating the cyclopropane remained intact after extensive reaction times. Sc(OTf)3 proved
to be a suitable catalyst improving yields significantly from less than 50% to the mid to
high 80's at room temperature and standard reaction times.
Paralleling problems with aliphatic cyclopropanes, aliphatic aldehydes were particularly
obstinate with this methodology. For example isobutyraldehyde proved to be a far too
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stubborn reagent to work with. All three component coupling reactions involving this
reagent required twice the amount of catalyst (20 mol %), hydroxylamine (2.6 equiv.),
aldehyde (2.8 equiv.) and reaction times (48 h) in order to completely consume the
cyclopropane. This is theorized to be due to the fact that aliphatic substitution cannot
effectively stabilize the partial positive charge on the nitrone. Due to the repeated
complications encountered with it, all examples with isobutryaldehdye were abandoned
after formation of the 3,6-dihydro-1,2-oxazine.

2.2.3 Tsuji Reaction and Conversion to 4,5-Dihydro-1,2-oxazines
The next phase in our work was to investigate how well the tetrahydro-1,2-oxazines
would fare in their conversion to 4,5-dihydro-1,2-oxazines using Tsuji's reaction. At this
point in time it has proven difficult to functionalize this position with tetrahydro-1,2oxazines. It was believed that this double bond would allow access to a variety of new
frameworks through various reactions; cross couplings, Diels-Alder reactions etc.. Using
the conditions previously optimized by a colleague the corresponding substrate scope was
conducted according to Table 2.2.8

Table 2.2 4,5-Dihydro-1,2-oxazines synthesized using the Pd0 dehydrocarbonylation.
R1

R2

R3

Yield (%)

Compound

Ph

Ph

Ph

66

2-8a

Ph

Ph

(E)-styryl

46

2-8b

Ph

Ph

2-furyl

86

2-8c

Ph

Ph

i-Pr

70

2-8d

Ph

Ph

4-O2N-C6H4-

79

2-8e

Ph

Tol

4-MeO-C6H4-

79

2-8f

Et

Ph

Ph

85

2-8g

Et

Ph

2-furyl

89

2-8h
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Tsuji's reaction was only successful when in refluxing CH3CN and takes approximately 3
hours to complete. All the 4,5-Dihydro-1,2-oxazines produced were formed as a single
isomer with the double bond between carbons four and five of the ring. In some cases the
3,6-dihydro-1,2-oxazine (2-8a-c, 2-8g-h) produced had the same retention factor as dba.
To circumvent this a NaBH4 workup was carried out in order to reduce the ketone on dba
allowing the product to be separated from the ligand. In all but one case the reaction
proceeded in modest to excellent yields (66-86%) with exception of 2-8b, only a
maximum 46 % yield was ever obtained.
There is however one minor drawback to using this methodology. As it currently stands
aliphatic nitrones have to be avoided because dehydrocarbonylation reactions with
aliphatic or benzylic nitrogen substitution are not tenable. Only aniline analogues have
shown success with this reaction. It is speculated that the more basic nitrogen of aliphatic
and benzylic nitrones coordinate to the Pd species thus interfering in the catalytic cycle
resulting in poor catalyst turn-over. Reactions performed on these substrates show poor
conversion or fail to react entirely (Figure 2.5).

Figure 2.5 Limitations of the dehydrocarbonylation reaction
After this work was completed a few test reactions were conducted to explore whether or
not quaternization of an aliphatic nitrogen would allow for conversion to the 4,5-dihydro1,2-oxazine. Unfortunately all attempts to first quaternize the 4,5-dihydro-1,2-oxazines
failed regardless of what agent was used.
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2.2.4 Discovery of the Dihydro-1,2-oxazine to Pyrrole Transformation
As was our initial intentions, the 4,5-dihydro-1,2-oxazines were subjected to various
reaction conditions in hopes that they would partake in some synthetically useful
transformation. Whether a Diels Alder reaction or any type of cross coupling was
attempted none of the expected product ever formed. There was just continuous recovery
of starting material and miniscule amounts of an undesired side product whose identity at
first perplexed us. Upon researching the 4,5-dihydro-1,2-oxazine heterocycle it was
discovered that under basic conditions they had the potential to expel water and ring
contract to form a pyrrole.9 We began to question then whether or not the byproduct of
the attempted reactions was none other than a pyrrole. Upon further investigation and
spectroscopic analysis it was concluded that the byproduct in all cases was a pyrrole.
Figure 2.6 is the crystal structure of the first pyrrole that was synthesized and fully
characterized confirming previous theories.

Figure 2.6 Crystal structure of pyrrole 2-12d
Pyrrole formation is not that surprising however after fully analyzing the 4,5-dihydro-1,2oxazine functionality. It is likely that the proton on C6 of the 4,5-dihydro-1,2-oxazines
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would be acidic enough to be removed by the basic media of the reaction and result in
N-O bond cleavage and subsequent condensation resulting in the pyrrole ring.9 This is
due to a combination of the vinylogous acidity to the methyl ester, the proximity to the
oxygen in the ring system and in some cases the anion stabilizing effect of the adjacent
aromatic ring. The proposed mechanism for this transformation can be seen in Figure
2.7.5a

Figure 2.7 Mechanism for the conversion of 4,5-Dihydro-1,2-oxazines into pyrroles
Initial attempts to optimize this conversion were unsuccessful. It was believed that a
significant degree of heating would be necessary to drive the reaction forward to facilitate
high conversion. Preliminary reactions were all carried out at reflux or with microwave
irradiation (Table 2.3).

Table 2.3 Initial attempts at converting 4,5-Dihydro-1,2-oxazines into pyrroles.
3,6-dihydro-1,2-

Equiv. of DBU

Conditions

Results

2-7a

3

120 °C, 2h, µw

Decomposition

2-7a

3

100 °C, 30 min, µw

Decomposition

2-7a

3

reflux, 2h

Decomposition

oxazine

Repeated decomposition of starting material meant that the reaction was likely far more
facile than originally thought. Moving to significantly milder conditions the 4,5-Dihydro1,2-oxazines were treated with NEt3 (3 equiv.) in CH3CN at room temperature for 24
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hours. This resulted in a new highly UV active spot on the TLC plate which was
determined to be the desired pyrrole.
It was later determined that DBU was a much more effective base for the elimination
reaction with all the 4,5-Dihydro-1,2-oxazines except compound 2-8e. Using DBU in
stead of NEt3 yields increased on average by 10 % and the reaction time decreased a
substantial amount, from 24 h to less than 5 minutes. Reactions that proceeded longer
than 5 minutes started causing decomposition of the newly formed pyrrole. For
compound 2-8e however NEt3 resulted in a higher yield, with a 20% average yield
increase between all attempts with DBU it did however require the usual 24 h reaction
time. Furthermore it is important to point out that when R1 was ethyl, NEt3 was not a
strong enough base to promote the elimination reaction in the first place even under
reflux conditions. Moreover when R1 was ethyl a minimum of 24 hours at 40 °C in the
presence of DBU was necessary for the reaction to go to completion. Stopping the
reaction any earlier would result in isolating a mixture of product and starting material.
The general transformation can be seen in Scheme 2.5.

Scheme 2.5 Conversion of 4,5-dihydro-1,2-oxazines into pyrroles
After determining the optimal conditions for both the dehydrocarbonylation reaction and
pyrrole conversion a one pot method was attempted in order to see if the tetrahydro-1,2oxazines could be converted into pyrroles directly. To do so the dehydrocarbonylation
reaction was carried out under the same conditions and after the allotted time the reaction
was cooled to room temperature and DBU was added directly. Table 2.4 shows the small
subset of different pyrroles synthesized for investigatory purposes by both a one pot
procedure and two pot with their respective yields.
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Table 2.4 Two reaction conversion of tetrahydro-1,2-oxazines to pyrroles.
Tetrahydro-

Pyrrole

1,2-oxazine

Reaction A

Reaction B

Overall

One Pot

Yield (%)

Yield (%)

Yield (%)

Yield (%)

2-7a

2-12a

66

88

58

76

2-7e

2-12d

79

98

77

79

2-7f*

2-12e

79

96

76

95

* NEt3 was used instead of DBU for 24 h at room temperature.

Much to our delight there was an improvement going from the two reactions to the one
pot. As such all of the pyrroles were synthesized using the one pot procedure. Table 2.5
shows the yields of each pyrrole synthesized using the one pot procedure.

Table 2.5 Various pyrroles synthesized from a one pot reaction.

a

R1

R2

R3

Yield (%)

Compound

Ph

Ph

Ph

76

2-12a

Ph

Ph

(E)-styryl

48

2-12b

Ph

Ph

2-furyl

69

2-12c

Ph

Ph

4-O2N-C6H4-

79

2-12da

Ph

4-tol

4-MeO-C6H4-

95

2-12e

Et

Ph

Ph

73

2-12fb

Et

Ph

2-furyl

50

2-12gb

NEt3 was used instead of DBU, bheated at 40 °C overnight
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2.3 Conclusions
As demonstrated the 1-ally-1-methylcyclopropane-1,1-dicarboxylates proved to be
exceptional substrates for the [3+3] cycloaddition reaction. A wide variety of tetrahydro1,2-oxazines could be synthesized as diastereomeric mixtures with outstanding yields.
The reaction supported a wide range of substitution however due to the requirements of
subsequent reactions the substrate scope was limited to N-aryl hydroxylamines. The Naryl tetrahydro-1,2-oxazines with the decreased nucleophilicity at nitrogen behaved as
desired in the catalytic dehydrocarbonylation reaction. The overall yields of this reaction
were modest but the most intriguing aspect of the chemistry of the dihydro-1,2-oxazines
was their rapid conversion to pyrroles. Utilizing a one pot reaction drastically increased
the overall yield of the pyrroles.
In summary the multi-component synthesis of pyrroles through the use of DA
cyclopropanes could very well prove to be a commonly used route to synthesize
pharmaceutically active compounds.

2.4 Experimental
2.4.1 General Considerations
All reactions were performed under an atmosphere of Ar unless otherwise indicated.
Toluene, acetonitrile, N,N-dimethylformamide (DMF), and dichloromethane were dried
and deoxygenated by passing the nitrogen purged solvents through activated alumina
columns. All other reagents and solvents were used as purchased from Sigma Aldrich,
Alfa Aesar, Caledon, Strem or VWR and used as received. Reaction progress was
monitored by TLC (EM Science, silica gel 60 F254), visualizing with UV light, and the
plates developed with p-anisaldehyde, vanillin, or basic potassium permanganate stains.
Column chromatography was performed using silica gel (230-400 mesh, Silicycle
Chemical Division Inc).
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NMR experiments were performed on Varian Mercury 400, Inova 400 and Inova 600
MHz instruments with 13C operating frequencies of 100, 100 and 125 MHz respectively.
Chemical shifts are reported in ppm relative to the residual solvent signal (CDCl3,
referenced to residual CHCl3 at δ = 7.26 for 1H and δ = 77.0 for 13C). Coupling constants
(J) are reported in Hz, and multiplicities of the signals are described using the following
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad.
High resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 or 8400
mass spectrometer at an ionizing voltage of 70 eV. Melting points were determined
using a Gallenkamp melting point apparatus and are uncorrected. Infrared spectra were
obtained as thin films on NaCl plates using a Bruker Vector 33 FT-IR instrument and are
reported in frequency of absorption (cm-1).

2.4.2 General

Procedure

and

Spectral

Data

for

1,1-

cyclopropanediesters

To a 1M solution of NaOH (1.2eq.) in an equal volume of MeOH was added the desired
1,1-dimethylcyclopropane-1,1-dicarboxylate. Upon complete saponification of one ester
based on TLC analysis the reaction was acidified to pH 4 with 4M HCl and the
cyclopropane was extracted with Et2O. Removal of solvent under reduced pressure
afforded the cyclopropane ester acid. The ester acid was then dissolved in DMF and
cooled to 0°C. At this point 1.1eq. of K2CO3 was added in and the solution was allowed
to stir for 30 minutes. After which time allyl bromide was added dropwise and the
reaction mixture continued to stir until the ester acid was consumed based on TLC
analysis. From here H2O was added to the reaction flask and the organics were extracted
with Et2O and the cyclopropane methyl allyl diesters were purified by flash column
chromatography (10% EtOAc in hexanes).
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(1R*,2S*)-1-allyl-1-methyl-2-phenylcyclopropane-1,1-dicarboxylate
CO2 Me
CO2 allyl

-

(2-10a): yellow oil; Rf = 0.50 (30% EtOAc/hexanes); ); 1H NMR (600
MHz, CDCl3) δ 7.28−7.19 (m, 5H), 5.93 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H),

5.35 (dq, J = 18, 1.8 Hz, 1H), 5.25 (dq, J = 9 Hz, 1.2 Hz, 1H), 4.69 (ddt, J = 5.4, 1.8 Hz,
2H), 3.37 (s, 3H), 3.25 (t, J = 8.6 Hz, 1H), 2.21 (dd, J = 7.8, 5.1 Hz, 1H), 1.76 (dd, J =
9.4, 5.1 Hz, 1H);

13

C NMR (400 MHz, CDCl3) δ 169.4, 166.9, 134.5, 131.6, 128.4,

128.1, 127.4, 118.2, 110.8, 66.1, 52.1, 42.1, 37.3, 32.5, 19.1; FT-IR (thin film, cm-1) νmax
2951, 1728 , 1500, 1437, 1382, 1333, 1274, 1217, 1180, 1130, 984, 933, 793, 750, 698,
453, 418; HRMS calc’d for C15H16O4 [M+] 260.1049, found 260.1042.

CO2 Me
CO2 allyl

(1R*,2R*)-1-Allyl-1-methyl-2-ethylcyclopropane-1,1-dicarboxylate

(2-

10b): Colourless oil; Rf = 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz,

CDCl3); δ 5.95−5.83 (m, 1H), 5.31 (dq, J = 17.2, 1.6 Hz, 1H), 5.22 (dq, J = 10.6, 1.6 Hz,
1H), 4.96−4.55 (m, 2H), 3.76 (s, 3H), 1.89 (quintet, J = 7.8 Hz, 1H), 1.49−1.36 (m, 3H),
1.29−1.20 (m, 1H), 1.00 (t, J = 7.4 Hz, 3H);

13

C NMR (400 MHz, CDCl3) δ 170.1,

168.7¸ 131.8, 118.0, 65.8, 52.4, 34.2, 30.4, 22.1, 21.2, 13.2; FT-IR (thin film, cm-1) νmax
2965, 1728, 1437, 1329, 1283, 1260, 1209, 1131, 1103; HRMS calc'd for C11H16O4 [M+]
212.1049, found 212.1045.

2.4.3 Synthesis of Tetrahydro-1,2-oxazines
General Method A – Two-Component Coupling
The desired nitrone (1.3 equiv) was added to a solution of 1,1-cyclopropanediester (1.0
mmol) and Yb(OTf)3 (10 or 20 mol %) in toluene (5−10 mL). The reaction was stirred at
room temperature, for the time indicated, under an atmosphere of argon. On completion,
the reaction mixture was filtered through celite, pre-adsorbed onto silica gel, and purified
by column chromatograpy (silica gel, EtOAc/hexanes).
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General Method B – Three-Component Coupling
Hydroxylamine (1.3 mmol), aldehyde (1.4 mmol) and Yb(OTf)3 (10 or 20 mol %) were
stirred under an atmosphere of argon at room temperature in the presence of 4 Å
molecular sieves in toluene (5−10 mL) for 0.5 h. Once the nitrone was formed in situ,
1,1-cyclopropanediester (1.0 mmol), dissolved in 1−2 mL of toluene, was added to the
reaction mixture in one portion. The reaction was stirred at room temperature, for the
time indicated, under an atmosphere of argon. On completion, the reaction mixture was
filtered through celite, pre-adsorbed onto silica gel, and purified by column
chromatograpy (silica gel, EtOAc/hexanes).

4-Allyl-4-methyl-2,3,6-triphenyl-1,2-oxazine-4,4-dicarboxylate
N

O

CO2Me
CO2allyl

(2-

7a): Following general procedure B, phenylhydroxylamine (55 mg, 0.50
mmol), benzaldehyde (57 mg, 55 uL, 0.54 mmol), cyclopropane 1 (0.10

g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave
4, after filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%),
as a pale yellow viscous oil (91 %, 0.16 mg, 0.35 mmol, 1:1 diastereomeric mixture at
C4); Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.62−7.54 (m, 7H),
7.47 (t, J = 7.0 Hz, 3H), 7.42−7.37 (m, 2H), 7.22−7.16 (m, 6H), 7.15−7.08 (m, 6H),
6.84−6.79 (m, 2H), 5.99 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H), 5.81 (s, 2H), 5.64 (ddt, J =
17.2, 10.6, 5.5 Hz, 1H), 5.41 (dq, J = 17.2, 1.2 Hz, 1H), 5.30 (dq, J = 10.2, 1.2 Hz, 1H),
5.21−5.13 (m, 2H), 5.05 (dt, J = 12.1, 2.7 Hz, 2H), 4.84 (dt, J = 5.9, 1.2 Hz, 1H), 4.39
(dd, J = 15, 6 Hz, 1H), 4.28 (dd, J = 15, 6 Hz, 1H), 3.93 (s, 3H), 3.48 (s, 3H), 2.94−2.77
(m, 4H); 13C NMR (100 MHz, CDCl3) δ 170.0, 169.1, 168.1, 167.4, 148.5, 139.4, 135.0,
134.8, 131.4, 131.0, 130.6, 130.3, 128.6, 128.5, 128.4, 128.2, 128.1, 128.0, 127.9, 127.9,
127.3 126.4 126.3 78.8, 66.7, 66.2, 65.8, 59.5, 53.4, 52.5, 37.3, 32.4, 31.7, 31.6, 19.0;
FT-IR (thin film, cm-1) νmax 3030, 2952, 1732, 1599, 1942, 1453, 1228, 1064, 988, 944,
911, 810, 734, 700, 650, 600; HRMS calc’d for C28H27NO5 [M+] 457.1889, found
457.1886.
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N

O

CO2Me
CO 2allyl

4-Allyl-4-methyl-2,6-diphenyl-3-[(E)-styryl]-1,2-oxazine-4,4dicarboxylate

(2-7b):

Following

general

procedure

B,

phenylhydroxylamine (55 mg, 0.50 mmol), cinnamaldehyde (71 mg,

67 uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol
%) heated in toluene (5 mL) for 20 h, gave 5, after filtration and purification (column
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (89 %, 0.17 g,
0.35 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.56 (30%, EtOAc/hexanes); 1H
NMR (400 MHz, CDCl3) δ 7.54−7.51 (m, 4H), 7.44 (t, J = 7.0 Hz, 4H), 7.39−7.36 (m,
2H), 7.26−7.17 (m, 14H), 7.14 (app d, J = 9.0 Hz, 4H), 6.91 (t, J = 7.0 Hz, 2H),
6.50−6.47 (m, 4H), 5.99 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H), 5.80 (ddt, J = 17.2 , 10.6, 5.9
Hz, 1H), 5.42 (dq, J = 17.2, 1.6 Hz 1H), 5.32−5.29 (m, 2H), 5.25−5.23 (m, 2H), 5.16 (dd,
J = 10.2, 1.2 Hz, 1H), 5.07−5.02 (m, 2H), 4.83 (d, J = 5.5 Hz, 2H), 4.56 (dq, J = 5.9, 1.6
Hz, 2H), 3.92 (s, 3H), 3.68 (s, 3H), 2.82 (d, J = 14.0 Hz, 2H), 2.62−2.55 (m, 2H);

13

C

NMR (100 MHz, CDCl3) δ 169.6, 168.7, 168.3, 167.6, 148.7, 139.6, 139.5, 136.7, 136.5,
136.3, 136.2, 131.5, 131.3, 128.6, 128.5, 128.4 (×2), 128.3, 127.8, 126.6, 126.4 (×2),
122.1, 120.1, 120.5, 119.1, 118.9, 116.3, 78.9, 66.8, 66.7, 66.5, 59.4, 55.3, 52.9, 32.6,
32.5; FT-IR (thin film, cm-1) νmax 3027, 2951, 1739, 1598, 1494, 1451, 1436, 1273,
1234, 1045, 967, 751, 695. HRMS calc’d for C30H29O5N [M+] 483.2046, found
483.2052.

N

O

O

CO 2Me
CO2allyl

4-Allyl-4-methyl-3-(furan-2-yl)-2,6-diphenyl-1,2-oxazine-4,4dicarboxylate

(2-7c):

Following

general

procedure

B,

phenylhydroxylamine (54 mg, 0.50 mmol), 2-furaldehyde (52 mg, 45

uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %)
heated in toluene (5mL) for 20 h, gave 6, after filtration and purification (column
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (93 %, 0.16 g,
0.36 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.48 (30%, EtOAc/hexanes); 1H
NMR (400 MHz, CDCl3) δ 7.58−7.54 (m, 4H), 7.46 (app t, J = 7.0 Hz, 4H), 7.42−7.38

39

(m, 2H), 7.33−7.30 (m, 2H), 7.29−7.24 (m, 4H), 7.16 (d, J = 8.2 Hz, 4H), 6.97 (app t, J =
7.0 Hz, 2H), 6.34 (dd, J = 3.5, 10.6 Hz, 2H), 6.25 (q, J = 2.0 Hz, 2H), 6.08-5.99 (m, 1H),
5.93 (s, 2H), 5.81−5.71 (m, 1H), 5.46 (dq, J = 17.2, 1.6 Hz, 1H), 5.34 (d, J = 10.6 Hz,
1H), 5.28−5.21 (m, 2H), 5.14−5.10 (m, 2H), 4.88 (d, J = 5.5 Hz, 2H), 4.56 (d, J = 5.5 Hz,
2H), 3.96 (s, 3H), 3.67 (s, 3H), 2.93−2.83 (m, 4H);

13

C NMR (100 MHz, CDCl3) δ

169.3, 168.4, 168.0, 167.2, 148.5, 148.4, 141.9, 141.8, 139.5, 131.4, 131.1, 128.5, 128.2,
126.5, 126.4, 122.3 (×2), 119.0, 118.9, 116.3, 116.2, 110.9, 110.1, 79.0, 66.8, 66.4, 61.7,
58.3, 53.4, 52.8, 32.9, 32.8; FT-IR (thin film, cm-1) νmax 3063, 3032, 2953, 2255, 1740,
1599, 1492, 1453, 1221, 1063, 1045, 1029, 1014, 911, 800, 736, 698, 649, 599; HRMS
calc’d for C26H25NO6 [M+] 447.1682; found 447.1700.

N

O

CO2Me
CO2allyl

4-Allyl-4-methyl-3-isopropyl-2,6-diphenyl-1,2-oxazine-4,4dicarboxylate

(2-7d):

Following

general

procedure

B,

phenylhydroxylamine (54 mg, 0.50 mmol), isobutyraldehyde (39 mg, 49

uL, 0.54 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3 (24 mg, 10 mol %)
heated in toluene (5 mL) for 20 h, gave 7, after filtration and purification (column
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (85 %, .14 g,
0.33 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.53 (30%, EtOAc/hexanes); 1H
NMR (400 MHz, CDCl3) δ 7.50−7.45 (m, 4H), 7.41 (app t, J = 7.0 Hz, 4H), 7.39−7.34
(m, 2H), 7.25−7.19 (m, 4H), 7.06−7.04 (m, 4H), 6.79 (app t, J = 7.0 Hz, 2H), 5.97-5.85
(m, 2H), 5.37 (dq, J = 9.8, 1.2 Hz, 1H), 5.35−5.23 (m, 3H), 4.83 (quintet, J = 4.7 Hz,
2H), 4.77−4.64 (m, 5H), 4.60−4.53 (m, 1H), 3.80 (s, 3H), 3.76 (s, 3H), 2.72−2.67 (m,
4H), 2.45 (sextet, J = 7.4 Hz, 2H), 0.93 (t, J = 6.3 Hz, 6H), 0.87 (dd, J = 6.6, 3.5 Hz, 6H);
13

C NMR (100 MHz, CDCl3) δ 170.3, 169.5, 169.4, 168.7, 149.2, 139.6, 131.6, 131.0,

128.8, 128.7, 128.5, 128.2, 126.4, 126.3, 119.1, 119.0, 118.9, 112.3, 112.4, 79.2, 66.6,
66.4, 66.2, 58.8, 53.1, 52.6, 33.5, 29.5, 22.4, 21.9; FT-IR (thin film, cm-1) νmax 2953,
1738, 1597, 1494, 1454, 1435, 1241, 1203, 1175, 1091, 1056, 987, 938, 749, 696, 605,
543; HRMS calc’d for C25H29NO5 [M+] 423.2046, found 423.2041.
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4-Allyl-4-methyl-3-(4-nitrophenyl)-2,6-diphenyl-1,2-oxazine-4,4N

O2 N

O

dicarboxylate (2-7e): Following general procedure A, nitrone (0.12

CO 2Me
CO2allyl

g, .50 mmol), cyclopropane 1 (0.10 g, 0.38 mmol), and Yb(OTf)3
(24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave 8, after

filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%), as a pale
yellow powder (94 %, 0.18 g, 0.36 mmol, 1.03:1 diastereomeric mixture at C4); Rf =
0.36 (30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 810−8.01 (m, 3H),
7.83−7.76 (m, 3H) 7.58−7.52 (m, 3H), 7.49 (t, J = 7.0 Hz, 3H), 7.45−7.40 (m, 1H), 7.17
(t, J = 7.0 Hz, 3H), 7.08 (d, J = 7.8 Hz, 3H), 6.86 (t, J = 7.0 Hz, 1H), 6.06-5.94 (ddt, J =
17.2, 10.6, 5.9 Hz, 1H), 5.92 (s, 1H), 5.73-5.61 (ddt, J = 17.2, 10.6, 5.9 Hz, 2H), 5.42
(dd, J = 17.2, 1.8 Hz, 1H), 5.33 (d, J = 10.6, 1.8 Hz, 1H), 5.21−5.17 (m, 2H), 5.13−5.06
(dt, J = 12.1, 2.7 Hz, 3H), 4.86 (d, J = 5.5 Hz, 1H), 4.49−4.29 (m, 2H), 3.96 (s, 3H), 3.53
(s, 1H), 2.91 (d, J = 2.7 Hz, 1H), 2.87 (d, J = 2.7 Hz, 2H), 2.84−2.74 (m, 1H); 13C NMR
(100 MHz CDCl3) δ 169.4, 168.5, 167.8, 167.1, 148.0, 147.5, 142.7, 142.5, 138.8, 131.5,
131.3, 130.6, 128.8, 128.6, 126.3 (×2), 123.0 (×2), 122.3 (×2), 119.4 (×2), 115.8, 78.8,
66.6, 65.5, 59.2, 53.7, 31.6; FT-IR (thin film, cm-1) νmax 3034, 2953, 2361, 1740, 1598,
1522, 1493, 1453, 1349, 1255, 1227, 1177, 1065, 944, 911, 861, 754, 697, 598, 546;
HRMS calc’d for C28H26N2O7 [M+] 502.1740, found 502.1756.

N

MeO

O

CO2Me
CO2 allyl

4-Allyl-4-methyl-3-(4-methoxyphenyl)-6-phenyl-2-(p-tolyl)-1,2oxazine-4,4-dicarboxylate (2-7f): Following general procedure A,
the nitrone (0.12 g, 0.50 mmol), cyclopropane 1 (0.10 g, 0.38

mmol), and Yb(OTf)3 (24 mg, 10 mol %) heated in toluene (5 mL) for 20 h, gave 9, after
filtration and purification (column chromatography, EtOAc/hexanes 2, 4, 10%), as a
white powder (96 %, 0.19 g, 0.36 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.44
(30%, EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.64−7.51 (m, 8H), 7.48 (app t, J
= 7.0 Hz, 4H), 7.44−7.37 (m, 2H), 6.99 (app q, J = 8.2, 8H), 6.78−6.69 (m, 4H), 6.00
(ddt, J = 16.8, 10.6, 5.5 Hz, 1H), 5.78-5.63 (m, 3H), 5.42 (d, J = 17.2 Hz, 1H), 5.31 (d, J
= 10.6 Hz, 1H), 5.25−5.15 (m, 2H), 5.07 (d, J = 11.3 Hz, 2H), 4.85 (d, J = 5.1 Hz, 2H),
4.48−4.25 (m, 2H), 3.94 (s, 3H), 3.72 (s, 6H), 3.51 (s, 3H), 2.94−2.76 (m, 4H), 2.20 (s,
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6H);

13

C NMR (100 MHz, CDCl3) δ 170.1, 169.2, 168.3, 167.5, 159.1, 159.0, 146.3,

139.6, 131.8, 131.6, 131.5, 131.1, 130.9 (×2), 129.0, 128.6, 128.2, 127.0, 126.9, 126.4,
126.3, 118.8, 116.0, 113.2, 78.6, 66.7, 66.2, 65.6, 59.6, 54.9, 53.4, 52.5, 31.7, 31.6, 20.5;
FT-IR (thin film, cm-1) νmax 3031, 3002, 2953, 2837, 1740, 1610, 1580, 1511, 1454,
1305, 1254, 1177, 1081, 1035, 943, 911, 841, 762, 733, 699, 650, 602, 573, 532, 489;
HRMS calc’d for C30H31NO6 [M+] 501.2151, found 501.2151

N

4-Allyl-4-methyl-2,3-diphenyl-6-vinyl-1,2-oxazinane-4,4-

O

CO2Me
CO2 allyl

dicarboxylate

(2-7g):

Following

general

procedure

B,

phenylhydroxylamine (67 g, 0.61 mmol), benzaldehyde (70 g, 67 uL,

0.66 mmol), cyclopropane 2 (0.10 g, 0.47 mmol), and Sc(OTf)3 (23 mg, 10 mol %)
heated in toluene (5 mL) for 24 h, gave 10, after filtration and purification (column
chromatography, EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (84 %, 0.16 g,
0.40 mmol, 1:1 diastereomeric mixture at C4); Rf = 0.45 (30% EtOAc/hexanes); 1H
NMR (400 MHz, CDCl3) δ 7.55−7.50 (m, 4H), 7.20−7.11 (m, 10H), 7.09−7.04 (m, 4H),
6.79 (td, J = 7.0, 1.2 Hz, 2H), 5.95(ddt, J = 16.8, 10.2, 5.5 Hz, 1H), 5.71 (s, 2H), 5.65
(ddt, J = 17.2, 10.2, 5.5 Hz, 1H), 5.37 (dq, J = 17.2, 1.2 Hz, 1H), 5.26 (dd, J = 10.6, 1.2
Hz, 1H), 5.21−5.14 (m, 2H), 4.80−4.75 (m, 2H), 4.41−4.28 (m, 2H), 3.94−3.88 (m, 2H),
3.87 (s, 3H), 3.47 (s, 3H), 2.49−2.43 (m, 4H), 1.91−1.77 (m, 2H), 1.77-1.67 (m, 2H),
1.14 (td, J = 7.4, 2.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 170.2, 169.3, 168.4, 167.7,
148.7, 135.2, 135.0, 131.5, 131.1, 130.6, 130.4, 128.5, 127.9 (×2), 127.8, 121.2, 118.7
(×2), 115.5, 78.4, 66.6, 66.2, 65.4, 59.2, 53.3, 52.5, 30.9, 27.7, 10.1; FT-IR (thin film,
cm-1) νmax 3061, 3028, 2966, 2879, 1741, 1598, 1492, 1452, 1229, 1197, 1142, 1085,
1032, 954, 912, 810, 754, 701, 636, 599; HRMS calc’d for C24H27NO5 [M+] 409.1889,
found 409.1882.

N

O

O

CO 2Me
CO2allyl

4-Allyl-4-methyl-6-ethyl-3-(furan-2-yl)-2-phenyl-1,2-oxazinane-4,4dicarboxylate

(2-7h):

Following

general

procedure

B,
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phenylhydroxylamine (67 mg, 0.61 mmol), 2-furaldehyde (63 mg, 54 uL, 0.66 mmol),
cyclopropane 2 (0.10 g, 0.47 mmol), and Sc(OTf)3 (23 mg, 10 mol %) heated in toluene
(5 mL) for 24 h, gave 11, after filtration and purification (column chromatography,
EtOAc/hexanes 2, 4, 10%), as a pale yellow viscous oil (89 %, 0.17 g, 0.42 mmol, 1:1
diastereomeric mixture at C4); Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ 7.25−7.19 (m, 6H), 7.10−7.06 (m, 4H), 6.94−6.87 (m, 2H), 6.24 (dd, J = 8.2,
3.1 Hz, 2H), 6.18 (q, J = 4.0 Hz, 2H), 5.94 (ddt, J = 17.2, 10.2, 5.9 Hz, 1H), 5.80 (s, 2H),
5.72 (ddt, J = 17.2, 10.6, 5.9 Hz, 1H), 5.37 (dq, J = 16.0, 4.0 Hz, 1H), 5.27 (dd, J = 10.6,
1.2 Hz, 1H), 5.24-5.16 (m, 2H), 4.77 (d, J = 4.0 Hz, 2H), 4.51-4.48 (m, 2H), 3.96−3.86
(m, 2H), 3.87 (s, 3H), 3.62 (s, 3H), 2.54 (d, J = 12.0 Hz, 2H), 2.38−2.29 (m, 2H),
1.79−1.60 (m, 4H), 1.09 (td, J = 8.0, Hz, 6H);

13

C NMR (100 MHz, CDCl3) δ 169.5,

168.6, 168.3, 167.5, 148.8, 148.7, 148.6, 141.7, 141.6, 131.4, 131.3, 128.5, 122.0, 121.9,
118.8, 118.6, 115.9, 115.8, 110.8, 110.7, 110.1, 78.4, 78.4, 66.7, 66.3, 61.3, 61.2, 58.1,
58.0, 53.3, 52.8, 31.6, 31.5, 27.5, 27.4, 10.0; FT-IR (thin film, cm-1) νmax 2966, 2880,
2360, 1740, 1598, 1492, 1455, 1436, 1240, 1221, 1199, 1145, 1013, 964, 934, 757, 693,
599, 575; HRMS calc’d for C22H25NO6 [M+] 399.1682, found 399.1678.

2.4.4 Synthesis of 4,5-dihydro-1,2-oxazines
To a solution of tetrahydro-1,2-oxazine (1 mmol) in CH3CN (3−5 mL) was added
Pd2dba3 (6 mol %). The solution was placed under Ar and brought to reflux (80 °C) for 3
h. At this time, the reaction was cooled to room temperature and filtered through celite.
Note: for compounds co-eluting with dba (compound 2-8a-d, g, h), the following workup procedure was used: the reaction residue was dissolved in MeOH (3 mL) and NaBH4
(1.2 equiv/ mmol dba) was added to reduce dba to the corresponding alcohol because the
pyrroles and dba co-eluted. After all the dba was reduced based on TLC analysis the
organics were collected via extraction with Et2O. The extract was absorbed onto silca and
the solvent was removed by reduced pressure. Pure product was obtained by flash column
chromatography on silica gel (eluent: EtOAc in hexanes).
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Methyl-2,3,6-triphenyl-3,6-dihydro-2H-1,2-oxazine-4-carboxylate
N

O

(2-8a): Following the general procedure, tetrahydro-1,2-oxazine 2-7a

CO 2Me

(0.19 g, 0.74 mmol) and Pd2dba3 (40 mg, 6 mol %) were brought to

reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel column
chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8a (66%,
0.10 g, 0.28 mmol) as a white powder; Rf = 0.43 (30% EtOAc/hexanes); 1H NMR (400
MHz, CDCl3) δ 7.56−7.51 (m, 2H), 7.50−7.40 (m, 3H), 7.37−7.30 (m, 3H), 7.23−7.16
(m, 5H), 7.04 (d, J = 7.8 Hz, 2H), 6.91 (t, J = 7.0 Hz, 1H), 5.75 (s, 1H), 5.58 (s, 1H), 3.72
(s, 3H);

13

C NMR (100 MHz, CDCl3) δ 175.3 165.2, 148.0, 139.7, 136.7, 136.5, 131.1,

129.5, 128.9, 128.9, 128.6, 127.9, 127.7, 122.3, 117.0, 78.6, 62.9, 52.0; FT-IR (thin film,
cm-1) νmax 3061, 3031, 2951, 2846, 2360, 1719, 1598, 1493, 1453, 1436, 1245, 1078,
1029, 909, 735, 696, 667, 627, 696; HRMS calc’d for C24H21NO3 [M+] 371.1521, found
371.1519.

N

O

(3R,6R)-methyl-2,6-diphenyl-3-styryl-3,6-dihydro-2H-1,2-oxazine4-carboxylate (2-8b): Following the general procedure, tetrahydro-

CO2 Me

1,2-oxazine 2-7b (98 mg, 0.20 mmol) and Pd2dba3 (11 mg, 6 mol %)

were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8b
(46%, 37 mg, 0.09 mmol) as a yellow oil; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR
(400 MHz, CDCl3) δ; 7.51-7.41 (m, 5H), 7.32-7.24 (m, 7H), 7.22-7.13 (m, 4H), 6.95 (app
t, J = 7.4 Hz, 1H), 6.69 (d, J = 16.0 Hz, 1H), 6.33 (dd, J = 16.0, 7.4 Hz, 1H), 5.72 (s,
1H), 5.26 (d, J = 7.8 Hz, 1H), 3.81 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.1, 148.0,
139.6, 136.6, 134.7, 130.7, 129.0, 128.8 (x2), 128.4, 128.1, 127.6, 126.5, 124.5, 122.0,
116.2, 79.5, 60.4, 52.0; FT-IR (thin film, cm-1) νmax 3061, 3030, 2950, 2360, 2249, 1719,
1597, 1493, 1452, 1436, 1248, 965, 908, 758, 694, 504; HRMS calc’d for C26H23NO3
[M+] 397.1678, found 397.1687.
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(3S,6R)-methyl-3-(furan-2-yl)-2,6-diphenyl-3,6-dihydro-2H-1,2N

O

O

CO2Me

oxazine-4-carboxylate (2-8c): Following the general procedure,
tetrahydro-1,2-oxazine 2-7c (81 mg, 0.22 mmol) and Pd2dba3 (5.0 mg, 6

mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2oxazine 2-8c (86%, 55 mg, 0.19 mmol) as a white powder; Rf = 0.40 (30%
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.55-7.50 (m, 2H), 7.46-7.41 (m, 2H),
7.28-7.24 (m, 4H), 7.11 (app d, J = 7.8 Hz, 2H), 6.98 (app t, J = 7.0 Hz, 1H), 6.24-6.21
(m, 1H), 6.15 (d, J = 3.1 Hz, 1H), 5.69 (d, J = 16.0 Hz, 2 H), 3.77 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 165.0, 150.6, 147.9, 142.2, 140.6, 136.5, 129.0, 128.8, 128.6, 128.1,
122.6, 116.8, 110.1, 109.7, 79.2, 56.8, 52.1; FT-IR (thin film, cm-1) νmax 3031, 2951,
1721 1597, 1492, 1247, 1014, 803, 735, 697; HRMS calc’d for C22H19NO4 [M+]
361.1314 found 361.1318.

N

O

(3R,6R)-methyl-3-isopropyl-2,6-diphenyl-3,6-dihydro-2H-1,2oxazine-4-carboxylate (2-8d): Following the general procedure,

CO 2Me

tetrahydro-1,2-oxazine 2-7d (121 mg, 0.29 mmol) and Pd2dba3 (16 mg,

6 mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2oxazine 2-8d (70%, 67 mg, 0.20 mmol) as a yellow oil; Rf = 0.50 (30% EtOAc/hexanes);
1

H NMR (400 MHz, CDCl3) δ 7.42-7.37 (m, 5H), 7.35-7.30 (m, 2H), 7.11 (app d, J = 7.8

Hz, 2H), 6.96 (app t, J = 7.4 Hz, 1H), 6.87 (d, J = 2.0 Hz, 1H), 5.33 (t, J = 2.3, 1H), 4.33
(dd, J = 7.0, 2.4 Hz, 1H), 3.82 (s, 3H), 2.39 (m, J = 7.0 Hz, 1H), 1.14 (d, J = 6.6 Hz, 3H),
1.04 (d, J = 7.0 Hz, 3H);

13

C NMR (100 MHz, CDCl3) δ 166.5, 147.9, 137.7, 136.4,

131.3, 129.4, 129.0, 128.8, 128.4, 121.4, 115.9, 73.0, 59.4, 52.1, 33.0, 20.9, 19.8; FT-IR
(thin film, cm-1) νmax 2959, 2360, 1718, 1596, 1491, 1246, 1089, 745, 695; HRMS calc’d
for C21H23NO3 [M+] 337.1678, found 337.1673.
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Methyl-3-(4-nitrophenyl)-2,6-diphenyl-3,6-dihydro-2H-1,2N

O

CO2 Me

O 2N

oxazine-4-carboxylate (2-8e): Following the general procedure,
tetrahydro-1,2-oxazine 2-7e (92 mg, 0.18 mmol) and Pd2dba3 (10 mg,

6 mol %) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification
(silica gel column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2oxazine 2-8e (79%, 60 mg, 0.14 mmol) as a yellow powder; Rf = 0.36 (30%
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.03 (d, J = Hz, 2H), 7.52−7.43 (m,
8H), 7.21 (t, J = Hz, 2H), 7.01 (d, J = Hz, 2H), 6.93 (t, J = Hz, 1H), 5.78 (s, 1H), 5.63 (s,
1H), 3.73 (s, 3H);

13

C NMR (100 MHz, CDCl3) δ 182.9, 175.3, 164.8, 147.4, 145.1,

144.1, 140.8, 136.1, 130.3, 129.2, 129.1, 128.8, 127.8, 122.9, 116.8, 78.9, 62.6, 52.5; FTIR (thin film, cm-1) νmax 3033, 2951, 2361, 2340, 1717, 1596, 1520, 1492, 1454, 1437,
1347, 1247, 1108, 1078, 909, 833, 754, 736, 698; HRMS calc’d for C24H20N2O5 [M+]
416.1372, found 416.1367.

N

MeO

O

CO2 Me

Methyl-3-(4-methoxyphenyl)-6-phenyl-2-(p-tolyl)-3,6-dihydro2H-1,2-oxazine-4-carboxylate

(2-8f):

Following

the

general

procedure, tetrahydro-1,2-oxazine 2-7f (56 mg, 0.11 mmol) and Pd2dba3 (6.2 mg, 6 mol
%) were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8f
(79%, 37 mg, 0.09 mmol) as a white powder; Rf = 0.41 (30% EtOAc/hexanes); 1H NMR
(400 MHz, CDCl3) δ 7.53−7.50 (m, 2H), 7.48−7.39 (m, 3H), 7.31 (t, J = 1.2 Hz, 1H),
7.23−7.19 (m, 2H), 7.00 (d, J = 8.2 Hz, 2H), 6.92−6.89 (m, 2H), 6.73−6.99 (m, 2H), 5.71
(s, 1H), 5.47 (s, 1H), 3.72 (s, 3H), 3.71 (s, 3H), 2.24 (s, 3H);

13

C NMR (100 MHz,

CDCl3) δ 165.3, 159.0, 145.6, 139.4, 136.9, 131.5, 130.7, 129.1, 128.9, 128.8, 127.9,
117.3, 113.1, 78.5, 62.6, 55.0, 52.0, 20.7; FT-IR (thin film) νmax 3031, 2951, 2836, 1719,
1609, 1509, 1455, 1437, 1245, 1177, 1107, 1033, 908, 820, 733, 699, 648, 607; HRMS
calc’d for C26H25NO4 [M+] 415.1784, found 415.1786.
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(3R,6S)-methyl-6-ethyl-2,3-diphenyl-3,6-dihydro-2H-1,2-oxazine-4N

O

carboxylate (2-8g): Following the general procedure, tetrahydro-1,2-

CO2 Me

oxazine 2-7g (74 mg, 0.18 mmol) and Pd2dba3 (10 mg, 6 mol %) were

brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel column
chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8g (85%, 49
mg, 0.15 mmol) as a yellow oil; Rf = 0.50 (30% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ 7.25-7.15 (m, 9H), 7.01 (app d, J = 7.8 Hz, 2H), 6.89 (app t, J = 7.0 Hz, 1H),
5.48 (s, 1H), 4.65 (t, J = 6.3 Hz, 1H), 3.70 (s, 3H), 1.93-1.84 (m, 2H), 1.19 (t, J = 7.4 Hz,
3H);

13

C NMR (100 MHz, CDCl3) δ 165.2, 148.1, 140.4, 136.3, 130.7, 130.0, 129.6,

128.5, 127.6 (x2), 122.0, 116.8, 63.1, 51.9, 26.1, 10.1; FT-IR (thin film, cm-1) νmax 2967,
2360, 1720, 1597, 1492, 1453, 1244, 1077, 755, 697; HRMS calc’d for C20H21NO3 [M+]
323.1521, found 323.1521.

N

O

(3S,6S)-methyl-6-ethyl-3-(furan-2-yl)-2-phenyl-3,6-dihydro-2H-1,2-

O

oxazine-4-carboxylate
CO2Me

(2-8h):

Following

the

general

procedure,

tetrahydro-1,2-oxazine 2-7h ( mg, mmol) and Pd2dba3 (mg, 6 mol %)

were brought to reflux in CH3CN (5 mL) for 3 h. Filtration and purification (silica gel
column chromatography, EtOAc/hexanes 2, 4, 10%) provided dihydro-1,2-oxazine 2-8h
(%, mg, mmol) as a yellow oil; Rf = 0xx (30% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ;

13

C NMR (100 MHz, CDCl3) δ; FT-IR (thin film, cm-1) νmax; HRMS calc’d

for C18H19NO4 [M+] 313.1314 found .

2.4.5 Synthesis of Pyrroles
General Method: One pot synthesis;
To a solution of tetrahydro-1,2-oxazine (1 mmol) in CH3CN (5 mL) was added Pd2dba3
(6 mol %). The solution was placed under Ar and brought to reflux (80 °C) for 3 h. At
this time, the reaction was cooled to 40 °C and either NEt3 or DBU (3 equiv) was added
in one portion, and the reaction was stirred further for the time indicated. Upon
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completion (TLC analysis), the solution was filtered through celite and the solvent was
removed under reduced pressure. Purification of the residue by column chromatography
(silica gel, EtOAc/hexanes) gave the desired pyrroles.
Note: for compounds that co-elute with dba (dibenzylideneacetone ligand) (compounds
2-12a-c, f, g) the following work-up procedure was used: the reaction residue was
dissolved in MeOH (3 mL) and NaBH4 (1.2 equiv/ mmol dba) was slowly added. After
dba reduction (as based on TLC analysis), the mixture the organics were collected via
extraction with Et2O. The extract was absorbed onto silca and the solvent was removed
by reduced pressure. Purification was then effected by the above methods.

Methyl-1,2,5-triphenyl-1H-pyrrole-3-carboxylate (2-12a): Following
N

general method A, dihydro-1,2-oxazine 2-8a (38 mg, 0.10 mmol) and
DBU (45 µL, 0.30 mmol) in CH3CN (4 mL, 25 °C, 5 min) gave 2-12a

MeO2 C

(79%, 28 mg, 0.079 mmol).

Following general method B (one-pot procedure),

tetrahydro-1,2-oxazine 2-7a (57 mg, 0.12 mmol), Pd2dba3 (7 mg, 0.0072 mmol) in
CH3CN (5 mL, 80 °C, 3 h), followed by DBU (54 µL, 0.36 mmol) at room temperature (5
min) gave 2-12a (76%, 28 mg, 0.080 mmol) as a white powder; Rf = 0.45 (30%
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.25−7.12 (m, 11H), 7.11−7.07 (m, 2H),
6.95 (s, 1H), 6.94−6.91 (m, 2H), 3.73 (s, 3H);

13

C NMR (100 MHz, CDCl3) δ 165.1,

139.9, 137.8, 134.7, 132.1, 131.4, 131.2, 128.8, 128.6, 128.5, 128.0, 127.8, 127.6, 127.2,
126.8, 113.8, 110.8, 51.0; FT-IR (thin film, cm-1) νmax 3061, 2948, 2360, 2251, 1714,
1599, 1559, 1496, 1474, 1439, 1404, 1274, 1223, 1183, 1113, 912, 777, 760, 731, 696,
542; HRMS calc’d for C24H19NO2 [M+] 353.1416, found 353.1424.

(E)-methyl-1,5-diphenyl-2-styryl-1H-pyrrole-3-carboxylate
N

MeO2 C

(2-

12b): Following general method B tetrahydro-1,2-oxazine 2-7b (68
mg, 0.14 mmol), Pd2dba3 (7.5 mg, 0.008 mmol) in CH3CN (5 mL,

80 °C, 3 h), followed by DBU (57 µL, 0.41 mmol) at room temperature (5 min) gave 2-
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12b (79%, 42 mg, 0.10 mmol) as a yellow powder; Rf = 0.53 (30% EtOAc/hexanes); 1H
NMR (400 MHz, CDCl3) δ 7.54 (d, J = 16.8 Hz, 1H), 7.45−7.38 (m, 3H), 7.28−7.20 (m,
7H), 7.20−7.15 (m, 4H), 7.10−7.04 (m, 2H), 6.90 (s, 1H), 6.40 (d, J = 17.2 Hz, 1H), 3.90
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.5, 138.6, 137.5, 136.4, 136.0, 132.5, 131.8,
128.3, 129.1, 128.7, 128.6, 128.5, 128.0, 127.6, 127.0, 126.4, 117.0, 114.4, 111.9, 51.2,
27.3; FT-IR (thin film, cm-1) νmax 3059, 2947, 2360, 2339, 1701, 1652, 1597, 1494,
1473, 1449, 1275, 1244, 1212, 1090, 1071, 969, 759, 695; HRMS calc’d for C26H21NO2
[M+] 379.1572, found 379.1576.

Methyl-2-(furan-2-yl)-1,5-diphenyl-1H-pyrrole-3-carboxylate
N

(2-

12c): Following general method B tetrahydro-1,2-oxazine 2-7c (150

O

mg, 0.32 mmol), Pd2dba3 (18 mg, 0.019 mmol) in CH3CN (5 mL, 80 °C,

MeO2C

3 h), followed by DBU (140 µL, 0.96 mmol) at room temperature (5 min) gave 2-12c
(69%, 64 mg, 0.19 mmol) as a white powder; Rf = 0.40 (30% EtOAc/hexanes); 1H NMR
(400 MHz, CDCl3) δ 7.33 (s, 1H), 7.29−7.21 (m, 3H), 7.20−7.16 (m, 3H), 7.12−7.03 (m,
4H), 6.92 (s, 1H), 6.36 (d, J = 3.5 Hz, 1H), 6.34−6.31 (m, 1H), 3.80 (s, 3H);

13

C NMR

(100 MHz, CDCl3) δ 164.6, 142.7, 138.2, 135.9, 131.8, 129.2, 128.7, 128.6, 128.2, 128.0,
127.9, 127.1, 116.2, 113.1, 111.1, 110.6, 51.2; FT-IR (thin film) νmax 2948, 2361, 1715,
1598, 1498, 1465, 1272, 1227, 1190, 1115, 1074, 1005, 898, 821, 760, 698, 595, 554;
HRMS calc’d for C22H17NO3 [M+] 343.1208, found 343.1209.

Methyl-2-(4-nitrophenyl)-1,5-diphenyl-1H-pyrrole-3-

O2 N

N

MeO2C

carboxylate (2-12d): Following general method A, dihydro-1,2oxazine 2-8e (12 mg, 0.03 mmol) and DBU (13 µL, 0.09 mmol) in

CH3CN (5 mL, 25 °C, 5 min) gave 2-12d (95%, 11.4 mg, 0.028 mmol). Following
general method B tetrahydro-1,2-oxazine 2-7e (68 mg, 0.14 mmol), Pd2dba3 (7.5 mg,
0.008 mmol) in CH3CN (5 mL, 80 °C, 3 h), followed by NEt3 (57 µL, 0.41 mmol) at
room temperature (24 h) gave 2-12d (79%, 42 mg, 0.10 mmol) as a yellow powder; Rf =
0.42 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.08−8.05 (m, 2H),
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7.38−7.35 (m, 2H), 7.25−7.17 (m, 6H), 7.10−7.06 (m, 2H), 6.96 (s, 1H), 6.93−6.90 (m,
2H), 3.75 (s, 3H);

13

C NMR (100 MHz, CDCl3) δ 164.7, 147.0, 138.3, 137.2, 136.7,

136.1, 132.2, 131.5, 129.0, 128.7, 128.6, 128.3, 128.1, 127.3, 122.5, 114.9, 111.3, 51.2;
FT-IR (thin film, cm-1) νmax 2949, 2361, 2340, 1712, 1600, 1559, 1518, 1473, 1345,
1275, 1224, 1184, 1114, 855, 757, 727, 698; HRMS calc’d for C24H18N2O4 [M+]
398.1267, found 398.1276.

Methyl-2-(4-methoxyphenyl)-5-phenyl-1-(p-tolyl)-1H-pyrroleMeO

N
MeO2 C

3-carboxylate (2-12e): Following general method A, dihydro-1,2oxazine 2-8f (50 mg, 0.12 mmol) and DBU (54 µL, 0.36 mmol) in

CH3CN (4 mL, 25 °C, 5 min) gave 2-12e (98%, 47 mg, 0.12 mmol). Following general
method B tetrahydro-1,2-oxazine 2-7f (100 mg, 0.20 mmol), Pd2dba3 (11 mg, 0.011
mmol) in CH3CN (5 mL, 80 °C, 3 h), followed by DBU (90 µL, 0.60 mmol) at room
temperature (5 min) gave 2-12e (95%, 75 mg, 0.11 mmol) as a white powder; Rf = 0.37
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.22−7.15 (m, 2H), 7.12 (t, J =
2.0 Hz, 1H), 7.11−7.06 (m, 3H), 6.95 (d, J = 8.2 Hz, 2H), 6.89 (s, 1H), 6.82−6.73 (m,
4H), 3.77 (s, 3H), 3.73 (s, 3H), 2.26 (s, 3H);

13

C NMR (100 MHz, CDCl3) δ 165.2,

159.0, 140.0, 137.3, 135.3, 134.5, 132.4, 132.3, 129.2, 128.6, 128.5, 128.0, 126.7, 123.7,
113.4, 112.8, 110.6, 55.1, 50.9, 21.0; FT-IR (thin film, cm-1) νmax 2948, 2834, 1715,
1611, 1559, 1514, 1497, 1437, 1290, 1248, 1221, 1177, 1109, 1037, 839, 761, 735, 698,
534; HRMS calc’d for C26H23NO3 [M+] 397.1678, found 397.1668.

Methyl-5-ethyl-1,2-diphenyl-1H-pyrrole-3-carboxylate
N

MeO2 C

(2-12f):

Following general method B tetrahydro-1,2-oxazine 2-7g (63 mg, 0.16
mmol), Pd2dba3 (8.5 mg, 0.009 mmol) in CH3CN (5 mL, 80 °C, 3 h),
followed by DBU (70 µL, 0.47 mmol) at 40 °C (24 h) gave 2-12f (73%,

34 mg, 0.11 mmol) as a white powder; Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400
MHz, CDCl3) δ 7.30−7.24 (m, 3H), 7.18−7.14 (m, 5H), 7.07−7.02 (m, 2H), 6.56 (s, 1H),
3.69 (s, 3H), 2.39 (q, J = 7.4 Hz, 2H), 1.16 (t, J = 7.4 Hz, 2H);

13

C NMR (100 MHz,
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CDCl3) δ 165.3, 139.7, 137.8, 136.6, 131.6, 131.0, 128.8, 128.6, 127.9, 127.5, 127.2,
106.9, 50.8, 20.3, 12.7; FT-IR (thin film, cm-1) νmax 3061, 2969, 2946, 1712, 1597, 1529,
1497, 1484, 1436, 1412, 1237, 1218, 1146, 1114, 1010, 940, 914, 819, 763, 697; HRMS
calc’d for C20H19NO2 [M+] 305.1416, found 305.1414.

Methyl-5-ethyl-2-(furan-2-yl)-1-phenyl-1H-pyrrole-3-carboxylate
N
O
MeO2 C

(2-

12g): Following general method B tetrahydro-1,2-oxazine 2-7h (54 mg,
0.14 mmol), Pd2dba3 (7.4 mg, 0.008 mmol) in CH3CN (5 mL, 80 °C, 3 h),

followed by DBU (61 µL, 0.41 mmol) at 40 °C (24 h) gave 2-12g (50%, 20 mg, 0.07
mmol) as a white powder; Rf = 0.43 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)
δ 7.36−7.32 (m, 3H), 7.23 (d, J = 1.8 Hz, 1H), 7.18−7.11 (m, 2H), 6.54 (s, 1H), 6.33 (d, J
= 3.5 Hz, 1H), 6.29−6.24 (m, 1H), 3.77 (s, 3H), 2.37 (q, J = 8.2 Hz, 2H), 1.14 (t, J = 7.6
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.9, 144.3, 142.2, 138.1, 137.7, 128.8, 128.2,
128.0, 127.8, 114.7, 112.2, 110.5, 107.4, 51.1, 20.1, 12.7; FT-IR (thin film, cm-1) νmax
2970, 2360, 1711, 1598, 1517, 1498, 1469, 1375, 1242, 1225, 1162, 1117, 1006, 898,
821, 771, 738, 698, 595; HRMS calc’d for C22H17NO3 [M+] 295.1208, found 295.1203.
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3 Synthetic Studies Towards BM 212 and Atorvastatin
Calcium (Lipitor®)
3.1 Introduction
3.1.1 BM 212
In order to highlight the utility of the methodology outlined in Chapter 2, it was applied
to the attempted total syntheses of both BM 212, an antimycobacterial drug, and Lipitor®
(Figure 3.1).

Figure 3.1 Chemical structures of BM 212 and Lipitor®
BM 212 was originally synthesized in response to the increasing number of multidrug
resistant strains of Mycobaterium tuberculosis. With the aim of finding new drugs
capable of combating tuberculosis, BM 212 was endowed with potent and highly
selective antimycobacterial properties.1 BM 212 has shown more potent activity than that
of commonly used drugs to combat tuberculosis.2 Its current commercial synthesis as
described in the patent can be seen in Scheme 3.1.3
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Scheme 3.1 Commercial synthesis of BM 212
Although the patent does not go into any detail regarding the experimental procedures
involved in the synthesis of BM 212, the first step is a Stetter reaction between methyl
vinyl ketone and p-chlorobenzaldehyde. The Stetter reaction affords the iconic 1, 4diketone structure (3-3) needed to undergo a Paal-Knorr pyrrole synthesis with pchloroaniline. Finally condensation of N-methypiperazine onto formaldehyde followed
by an electrophillic aromatic substitution reaction completes BM 212.
The great success of BM 212 sparked the construction and search for new diaryl pyrroles
in order to achieve even higher biological activity.3 This simple molecule is gradually
elevating its status from a small di-aryl pyrrole to a compound that could revolutionize
the fight against tuberculosis.

3.1.2 Atorvastatin Calcium (Lipitor®)
Lipitor® is a member of the drug class called statins. Statins act to block an enzyme in the
liver, HMG-CoA reductase. This enzyme is responsible for cholesterol synthesis in the
body. Lipitor® is clinically proven to lower unwanted cholesterol by 40-60 % based on
dosage. Lipitor® was first synthesized in 1985 by Bruce Roth at Pfizer and it is
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considered to be the most successful drug in pharmaceutical history. Since its approval in
1996 Lipitor® generated on average US $13 billion in profit annually.4
The original synthesis by Roth involved the convergence of a cyano side chain (3-8) with
a 1,4-diketone (3-7). By effectively reducing the cyano group and carrying out a PaalKnorr pyrrole synthesis between the two components he was able to synthesize Lipitor®
asymmetrically and efficiently enough for industrial processing. The convergent
approach and synthesis of the 1,4-diketone subunit can be seen in Scheme 3.2.5 The first
major intermediate 3-7 was synthesized in two steps starting with isobutyrylacetanilide
(3-9). First a Knovenagle condensation between 3-9 and benzaldehyde afforded 3-10.
Next a Stetter reaction between p-fluorobenzaldehyde and 3-10 affords 3-7 in an overall
68 % yield.

Scheme 3.2 Convergent approach and synthesis of 1,4-diketone
Roth chose to synthesize the cyano side chain intermediate 3-8 in three separate ways.
Each synthesis was done successfully in minimal synthetic steps and could be scaled up
to multi kilogram levels. The three separate syntheses can be seen in Scheme 3.3.6
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Scheme 3.3 Syntheses of side chain
As you can see in Scheme 3.3 each synthesis starts from a commercially available
advanced intermediate. The first synthesis begins with a CDI coupling between ester 3-11
and oxanion 3-12 producing 3-13. 3-13 is then stereoselectively reduced and acetylated
affording the desired intermediate 3-8. The second synthesis differentiates from the first
only in the first step. It is initiated with a Claisen condensation between the commercially
available alcohol 3-15 and ester 3-16. This produces a common intermediate (3-13)
which is carried forward identically to the first synthesis. The final synthesis is
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considerably shorter than the other two. In the third synthesis alcohol 3-17 is derivatized
and then displaced with cyanide affording the desired intermediate 3-8.
The stage was now set for Roth to complete the synthesis of Lipitor®. The cyano group
was reduced with raney nickel under an atmosphere of H2 affording the necessary amine
(3-19) for the putative Paal-Knorr pyrrole synthesis. After some considerable tweaking
Roth found the required conditions to effectively promote the pyrrole formation.
Cleavage of the acetyl and saponification of the tBu ester affords the carboxylic acid form
of Lipitor® (Scheme 3.4).5

Scheme 3.4 Completion of Lipitor®

3.2 Results and Discussion
3.2.1 Retrosynthesis of BM 212
As seen in figure 3.1 BM 212 has the exact one, two, three, five substitution pattern that
was obtained from the methodology reported in Chapter 2. The only minute difference
being that instead of having a methyl ester at the three position there is a substituted
piperazine ring which could easily be installed in the final stages of the synthesis. The
proposed retrosynthetic outline can be seen in Figure 3.2.
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Figure 3.2 Proposed retrosynthesis for BM 212
As illustrated in the retrosynthesis it was envisioned that the methyl substituted
piperazine could be attached by performing an SN2 substitution reaction on the terminally
mesylated alcohol (3-21) with 1-methylpiperazine. 3-21 would come from an LAH
reduction of the methyl ester on the parent pyrrole ring (3-22). The pyrrole could be
formed using the aforementioned conditions, in Chapter 2, from tetrahydro-1,2-oxazine
3-23. 3-23 could be formed from a three component coupling between pchlorophenylhydroxylamine,

acetaldehyde

and

1-allyl-1-methyl-2-(4-

chlorophenyl)cyclopropane-1,1-dicarboxylate.

3.2.2 Synthesis of the Required Cyclopropane and Hydroxylamine
Of the material required for the [3+3] cycloaddition both the hydroxylamine (3-24) and
1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1-dicarboxylate (3-26) needed to be
synthesized. 3-26 was made in four steps from commercially available material,
beginning with a Knoevenagle condensation between dimethyl malonate and pchlorobenzaldehyde. Followed by a Corey-Chaykovsky cyclopropanation of 3-28
afforded 3-30 (Scheme 3.5).7,8
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Scheme 3.5 Preparation of geminal 1,1-dimetyl-2-(4-chlorophenyl)cyclopropane-1,1dicarboxylate
The mono-allylated cyclopropane (3-26) can be obtained from the diester cyclopropane
(3-30) via the standard mono-allylation procedure mentioned in chapter 2, with one slight
modification. Instead of a 1:1, H2O:MeOH solvent, a 1:1:1 solvent mixture of
H2O:THF:MeOH was used. This was altered because the solubility of 3-30 was poor in
the standard H2O:MeOH solvent. Treatment of the cyclopropane ester acid with allyl
bromide in DMF in the presence of K2CO3 produced the desired cyclopropane in an
overall 87 % yield over the final two steps (Scheme 3.6).9

Scheme 3.6 Preparation of 1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1dicarboxylate
The general procedure for the synthesis of aryl hydroxylamines is the reduction of the
correspond nitro compounds using a Zn dust suspension in H2O with NH4Cl.10 This
seemed to be a suitable starting point for the formation of p-chlorophenylhydroxylamine
(3-33). Upon subjecting p-chloronitrobenzene to the outlined reducing conditions only
the fully reduced aniline species was obtained (Scheme 3.7).

Scheme 3.7 Preparation of p-chlorophenylhydroxylamine
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After successive failures using the generic procedures it was concluded that the
conditions would not be adequate for the desired conversion. Continuing forwards and
hoping that perhaps adjusting the reaction time or reducing the equivalents of Zn would
allow for partial reduction. The reaction was repeated under the same reducing conditions
while varying the timeframe or amount of Zn. Regrettably, each successive attempt failed
to produce the hydroxylamine forcing us to revisit the literature in order to revise the
synthesis. To our delight, a recent paper described the synthesis of the exact
hydroxylamine from the parent nitro compound using an excess of Zn and NH4HCO2 in
CH3CN under sonicating conditions as seen in Scheme 3.8.11

Scheme 3.8 Formation of p-chlorophenylhydroxylamine
Regardless of reaction times 3-24 was never solely formed. With shorter reaction times a
mixture of starting material and product was continuously isolated. Prolonged reaction
times resulted in a three component mixture containing starting material, the
hydroxylamine and aniline species. In the interest of ease of separation a lower reaction
time was chosen to minimize the number of compounds needed to be separated by flash
column chromatography.

3.2.3 Investigation of the [3+3] Cycloaddition Towards BM 212
With all three of the necessary components in hand it was time to attempt formation of
the substituted tetrahydro-1,2-oxazine, precursor to BM 212 (Scheme 3.9).

Scheme 3.9 Three component coupling reaction for BM 212
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As per usual nitrone formation was attempted in-situ for 30 minutes prior to adding the
cyclopropane. While monitoring the reaction it was discovered that under the standard
timeline the nitrone was unable to form. This is not unexpected as there was some
precedence for this in Chapter 2 when using isobutraldehyde. Aliphatic aldehydes react
much slower in nitrone formation than aryl aldehydes. Furthermore the high volatility of
acetaldehyde substantially decreased the amount dissolved in the solution at any one time
further impeding nitrone formation by limiting the possibility of a constructive collision
occurring. To circumvent this problem the reaction was repeated with a significant excess
(10 equivalents) of acetaldehyde and nitrone formation was monitored by the
disappearance of p-chlorophenylhydroxylamine by TLC. Surprisingly no nitrone
formation took place when an excess of acetaldehyde was used. Sadly prolonged reaction
times at room temperature led to the decomposition of the 3-24. Once again the lack of
nitrone formation was attributed to the combination of high volatility and decreased
reactivity of acetaldehyde. To prevail over acetaldehyde’s low boiling point the reaction
flask was cooled to 0 °C in hopes that the high concentration of dissolved acetaldehyde
would surmount the possibility of attenuating the reaction rate. At 0 °C hydroxylamine
decomposition had also halted and all the components necessary for the reaction to occur
were now present and stable in solution. Yet again however nitrone formation failed to
take place even with prolonged reaction times. These results were not discouraging; it
was still believed that this reaction could be carried out successfully. Whether the
reaction required a different Lewis acid or heating in a sealed tube; reaction conditions
could be tailored to optimally promote the reaction. Table 3.1 shows the conditions
attempted for the in-situ formation of the nitrone and their specific results.
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Table 3.1 Various conditions used with acetaldehyde
Equiv. of
Hydroxylamine

Equiv. of

Conditions

Result

Aldeyhyde

1.3

1.4

Yb(OTf)3, RT, 30 min

No nitrone formation

1.3

1.4

Yb(OTf)3, RT, 2 h

Decomposition of
hydroxylamine

1.3

1.4

Yb(OTf)3, 0 °C, 2 h

No nitrone formation

1.3

2

Yb(OTf)3, 0 °C, 2 h

No nitrone formation

3

10

Yb(OTf)3, 0 °C, 2 h

No nitrone formation

3

10

Yb(OTf)3, 60 °C, 2 h

Decomposition of
hydroxylamine

3

10

Sc(OTf)3, 0 °C, 2 h

No nitrone formation

3

10

Yb(OTf)3, 110 °C,

Decomposition of
hydroxylamine

2 h, sealed tube

The equivalents of the hydroxylamine and aldehyde are compared to that of the cyclopropane (1equiv.). The catalyst loading was 10
mol %.

It was at this point that conclusions were drawn and perhaps forming the tetrahydro-1,2oxazine required for BM 212 via the three component coupling method was not going to
occur. In every case investigated no nitrone formation occurred before the hydroxylamine
began to decompose. Once again this is due to the diminished reactivity of aliphatic
aldehydes to nitrone formation and their inability to stabilize a partial positive charge.
In a final effort to synthesize 3-26 for BM 212 a more reactive masked version of
acetaldehyde was employed. In this case the three component coupling reaction was
carried out with chloral hydrate in place of acetaldehyde. The dehydrating conditions of
the reaction should be sufficient enough to generate the reactive aldehyde in-situ. The
resulting trichloromethyl group could then be reduced using Zn in the presence of AcOH
affording the desired tetrahydro-1,2-oxazine. The sequence of reactions proposed for this
method can be seen in Scheme 3.10.
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Scheme 3.10 Three component coupling with masked aldehyde
As has been the trend with BM 212 all attempted reactions with chloral hydrate failed
regardless of the conditions used. If the solution was cooled no nitrone formation would
occur and if the solution was heated the hydroxylamine would decompose prior to
reacting. It was at this point we concluded that perhaps BM 212 is not accessible by this
methodology due to the lack of reactivity of acetaldehyde. All experimental inquiries
towards BM 212 via this route were ceased and all focus turned towards Lipitor® which
contained an aliphatic iPr group which was previously shown to be compatible with the
[3+3] cycloaddition reaction.

3.2.4

Retrosynthesis of Lipitor®

The retrosynthetic outline for Lipitor® can be seen in Figure 3.3. The sequence itself is
linear in nature but this is due to the fact that after the initial three component coupling
reaction only two functional groups needed to be manipulated in order to produce the
final PMP-protected pyrrole.

63

Figure 3.3 Retrosynthetic outline for Lipitor
As outlined in the retrosynthesis the synthetic strategy culminates with the deprotection
of the tertiary pyrrole amine followed by a substitution reaction on a diastereomerically
pure statin side chain. The free N-H pyrrole would come from the deprotection of the
penta-substituted pyrrole ring 3-37. The phenyl ring at the four position could be installed
through a Suzuki coupling with phenyl boronic acid and 3-38. Prior to the Suzuki
reaction the four position of the pyrrole will be brominated with NBS. The pendant amide
will be formed through a coupling reaction between aniline and the acid of 3-39. This
would all come from the tetra substituted pyrrole ring, 3-39, afforded from the cascade
tandem dehydrocarbonylation, elimination and ring contraction reaction of 3-40. The
starting materials required for 3-40 are cyclopropane 3-43 isobutraldehyde (3-42) and
hydrolxylamine 3-41.

3.2.5 Investigations Towards the Total Synthesis of Lipitor®
The required fluorinated cyclopropane was made from the same sequence of reactions as
the previous ones had been. Begining with a Knoevenagle condensation between pflurobenzaldehdye

and

dimethylmalonate,

followed

by

a

Corey-Chaykosvky
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cyclopropanation. The resultant cyclopropane 3-45 was then allylated using the previous
procedure; the series of reactions can be seen in Scheme 3.11.7,9

Scheme 3.11 Preparation of 1-allyl-1-methyl-2-(4-fluorophenyl)cyclopropane-1,1dicarboxylate
The next undertaking which was anticipated to be trivial was the formation of PMPhydroxylamine. A PMP group was chosen as the protecting group because there is a great
deal of literature precedence for the removal of PMP groups from aromatic nitrogen
atoms using CAN. Also electron rich aryl hydroxylamines work well with both the [3+3]
annulation and pyrrole formation. However upon embarking down the published
synthetic route it was quickly discovered how complicated the synthesis of such a small
molecule can be. It has been previously reported that the hydroxylamine could be formed
from p-methoxynitrobenzene using Zn and NH4Cl. The original literature source
described an elaborate separation technique to remove the two major impurities, the
aniline species and starting material. However each time the reaction was carried out
regardless of how close or meticulous conditions were to matching the literature prep the
desired hydroxylamine was never isolated. The only products ever isolated were the over
reduced product or starting material (Scheme 3.12).12
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Scheme 3.12 Preparation of PMP-hydroxylamine
After successive failures with the literature procedure, 3-50 was subjected to the
sonicating conditions used to synthesize p-chlorophenylhydroxylamine (3-24). Under
sonicating conditions no product was obtained and only complete reduction took place.
At what seemed like an impasse some helpful insight by a colleague brought to our
attention some older literature work that had not been previously know to us. Still using
Zn as the reducing agent and NH4Cl as the proton source historically a vast number of
hydroxylamine had been synthesized using a H2O/ EtOH solvent mixture (entries 5 and
6).13 Switching to these conditions and using a crystallization, isolation method the
desired hydroxylamine had finally been synthesized. Table 3.2 shows the variety of
conditions used in attempted formation of 3-41, as well as the optimization of the
working conditions.
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Table 3.2 Various attempts at formation of PMP-hydroxylamine
Equiv. of
Zn

Equiv. of
Ammonium Salt

Conditions

Result

2

1.1 NH4Cl

H2O, 25 °C,
20 min

Starting material, or over
reduction

4

10.0 NH4HCOO

CH3CN, 30 °C,
sonicating, 1 h

Over reduction

2

1.1 NH4HCOO

CH3CN, 25 °C,
sonicating, 30 min

Over reduction

2

1.1 NH4Cl

Degassed H2O,
25 °C, 40 min

Over reduction

2

1.1 NH4Cl

H2O:EtOH (1:1),
25 °C, 15 min

1:1 mixture of product and
starting material

2

1.1 NH4HCOO

H2O:EtOH (3:1),
25 °C, 15 min

1:1 mixture of product and
starting material

4

1.05 NH4Cl

H2O:EtOH (1:1),
25 °C, 25 minutes

Optimized 60 % yield of
pure product

It is important to point out that hydroxylamine 3-41 was quite sensitive to ambient
conditions. Prolonged exposure to atmosphere would oxidize 3-41 back to starting
material (3-50). Also at room temperature 3-41 would decompose within a day. After
synthesizing 3-41, it was quickly put under an atmosphere of Ar and placed in the −20 °C
freezer for storage.
Ultimately after some considerable amount of time all the starting materials had been
synthesized in substantial quantities and the synthetic exploration our towards the total
synthesis of Lipitor® could commence.
The first step was the [3+3] cycloaddition reaction which proved to be so problematic
with the necessary starting material that the entire project was nearly abandoned. Initial
reactions were carried out by forming the nitrone in-situ from the hydroxlamine (3-41).
The general reaction schematic can be seen in Scheme 3.13.14
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Scheme 3.13 Three component coupling reaction for Lipitor®
Tetrahydro-1,2-oxazine formation (Scheme 3.13) did not go as planned and it was clear
that some of the same problems previously encountered with BM 212 were going to
occur here. PMP-hydroxylamine is prone to both chemical decomposition and oxidation.
Even under the anhydrous conditions that the reaction was carried out in the
hydroxylamine would rapidly decompose or oxidize to the nitro compound, making the
in-situ nitrone formation extremely difficult, if possible at all. A wide variety of
conditions were tried to generate the nitrone and they have been summarized in Table
3.3.
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Table 3.3 Attempted formation of the Lipitor® tetrahhydro-1,2-oxazine
Equiv. of
Hydroxylamine

Equiv. of
Aldeyhyde

Temperature

Catalyst

Result

1.3

1.4

25 °C

Yb(OTf)3

Decomposition of
hydroxylamine

1.3

1.4

0 °C

Yb(OTf)3

Decomposition of
hydroxylamine

1.3

1.4

0 °C

None

Decomposition of
hydroxylamine

1.3

1.4

25 °C

Sc(OTf)3

Decomposition of
hydroxylamine

2

2.2

60 °C

15 mol %
Sc(OTf)3

Decomposition of
hydroxylamine

3

10

25 °C

15 mol %
Sc(OTf)3

Decomposition of
hydroxylamine

*The equivalents of the hydroxylamine and aldehyde are compared to that of the cyclopropane (1equiv). The catalyst loading was 10
mol % unless otherwise stated.

Similar to BM 212 the aldehyde was slow to react with the hydroxylamine however
unlike BM 212 the hydroxylamine is extremely unstable regardless of the conditions
used. Hydroxylamine decomposition could not be avoided. At lower temperatures it was
postulated that the hydroxylamine would last long enough to react with the aldehyde;
while at higher temperatures and increased amounts of both reagents it was envisioned
that some nitrone would form even if the majority of the hydroxylamine decomposed.
Based on our experimental findings PMP-hydroxylamine is not compatible in the three
component coupling with isobutyraldehyde as its partner.
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Our general synthetic route towards Lipitor® remained unchanged. Either a different
hydroxylamine protecting group was required in order to proceed or the nitrone needed to
be formed separately.

To increase our chances of finding suitable substrates for

isobutraldehyde both BOC hydroxylamine and the nitrone generate from PMPhydroxylamine

and

isobutyradehyde

were

synthesized

simultaneously.

BOC-

hydroxylamine was synthesized according to the literature prep and was carried forward
in the desired three component coupling reaction (Scheme 3.14).15

Scheme 3.14 Synthesis and application of BOC-hydroxylamine
BOC-hydroxylamine was chosen because it satisfied the required conditions of the Tsuji
reaction. With a BOC group the nitrogen lone pair would be delocalized decreasing its
nucleophilicity. BOC-hydroxylamine however proved to be incompatible with the three
component coupling reaction. It would rapidly decompose faster than PMPhydroxylamine. This is not surprising however because it is well documented that BOC
groups are extremely labile under the mildest acidic conditions. Therefore the required
Lewis acid was rapidly decomposing the hydroxylamine. This method was quickly
discarded and our attention was refocused onto PMP-hydroxylamine.
Nitrone formation was carried according to previously used conditions. 3-42 and 3-41
were dissolved in anhydrous toluene in the presence of molecular sieves under Ar and
stirred overnight (Scheme 3.15).

Scheme 3.15 Nitrone formation
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After the allotted time the reaction was filtered and the solvent was removed under
reduced pressure keeping the water bath below 40 °C. The crude residue was dissolved in
a minimal amount of hexanes and placed in the freezer for crystallization. Gratifyingly
the nitrone precipitated out of solution as fine crystals overnight at −20 °C.
With an optimal route to the nitrone (3-55) one complication that arose was the
scalability of the two reactions required for nitrone formation. The largest mass of
starting material to begin with when reducing the p-methoxynitrobenzene is
approximately 5 g; anything above this amount consistently caused the yield to drop
drastically. Even after extensive work towards optimizing the reaction only a maximum
60 % yield was obtained for each individual step (nitro reduction and nitrone formation)
resulting in a maximum 36 % overall yield of the nitrone. The low mass recovery of the
desired compounds forced the synthesis of a large stock of the nitrone prior to continuing
onward with the annulation reaction.
At this point it was believed that the [3+3] cycloaddition could be facilitated with
cyclopropane 3-43 and nitrone 3-55. The reason being that the nitrone was significantly
more stable than the hydroxylamine precursor. Subjecting the starting material to the
same conditions as the previous three component coupling reaction should theoretically
generate some of the desired product. Tetrahydro-1,2-oxazine formation was carried out
according to Scheme 3.16.16

Scheme 3.16 Lipitor® tetrahydro-1,2-oxazine synthesis
Inexplicably upon working up the above reaction the majority of the cyclopropane was
recovered and all of the nitrone had decomposed. It was quite shocking to discover that
even with the enhanced stability of the nitrone not even trace amounts of the tetrahydro1,2-oxazine was observed. Curious as to whether or not slightly altering the conditions
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could promote product formation once again the Lewis acidity and temperature of the
reaction were systematically altered. The assortment of conditions attempted to form 3-42
and their individual results can be seen in Table 3.4.

Table 3.4 Attempted formation of Lipitor® tetrahydro-1,2-oxazine
Equiv. of

Catalyst Loading

Temperature

Result

1.3

10 mol % Yb(OTf)3

RT

Decomposition of nitrone

1.3

10 mol % Yb(OTf)3

0 °C

Decomposition of nitrone

1.3

20 mol % Yb(OTf)3

60 °C

Decomposition of nitrone

2.6

20 mol % Yb(OTf)3

RT

Decomposition of nitrone

1.3

10 mol % Sc(OTf)3

RT

Decomposition of nitrone

1.3

10 mol % Sc(OTf)3

80 °C

Decomposition of nitrone

Nitrone

*The equivalents of the nitrone are compared to that of the cyclopropane (1equiv).

Again regardless of the conditions no cycloaddition product was observed prior to
decomposition of the nitrone. It was not anticipated that the cyclopropane would persist
as long as it did under the elevated temperature and Lewis acidity. It has been shown that
at approximately 80 °C under Lewis acidic systems the 1,1-dimethylcyclopropane-1,1dicaboxylates could open and reclose forming all potential diastereomers.17 It was curious
then that 3-43 was being readily recovered almost in its entirety. It was postulated that
no cycloadditon between 3-55 and 3-43 was occurring due to a lack of reactivity of the
cyclopropane. Perhaps the p-fluorine substituent on the phenyl ring has such a drastic
effect on the phenyl rings donor capability that it will not open under normal conditions.
To investigate this theory we simultaneously scoured the literature looking for some
precedence of the predictions and paralleled this by testing 3-43 with some of the most
reactive species in the [3+3] cycloaddition. The test reaction can be seen in Scheme 3.17;
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previous work has shown that both benzaldehyde and phenylhydroxylamine can cyclize
with cyclopropanes rapidly and efficiently.

Scheme 3.17 Test cycloaddition with cyclopropane 3-45
In this case however when 3-43 was combined with the two afformentioned compounds
(3-56, 3-57) after the same reaction time a significant amount of unreacted nitrone and
cyclopropane was present. A 1H NMR experiment showed that in fact only 16 % of the
starting cyclopropane had been converted to product. When you directly compare this
result to previous examples it is unequivocally evident that the fluorine substitution is
significantly attenuating the reaction under the current conditions. This conclusion was
fortified when it was discovered that the result coincided with the information discovered
in the literature.18 In general Lewis acids have shown success with dimethyl-2-(4fluorophenyl)cyclopropane-1,1-dicarboxylate however these Lewis acids are typically
late transition metals or iodide containing salts. Using these newfound results and some
past experiences by a former group member, Mike Ganton who showed that the homo
[3+2] cycloaddition between a DA cyclopropane and a nitrone was effectively promoted
with MgI2. A reaction was attempted using 10 mol % MgI2 in anhydrous toluene
(Scheme 3.18).19

Scheme 3.18 MgI2 promoted cycloaddition
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This time fortunately the cycloaddition was successful providing the desired product in a
10:1 disatereomeric ratio. Upon optimization of the reaction a maximum 60 % yield was
achieved using 15 mol % catalyst and a reaction period of two days. The suboptimal yield
was accredited to again the rapid decomposition of the nitrone.
The next series of reactions, seen in Scheme 3.19, involved conversion of 3-42 to the
pyrrole using the cascade Tsuji dehydrocarbonylation reaction, elimination and ring
contraction sequence.20 The four position of 3-39 can be readily brominated with NBS
and it proceeds rapidly with no side reactions. Next a Suzuki cross coupling between
phenyl boronic acid and 3-58 afforded the fully functionalized pyrrole, 3-59.21 The next
step in the synthesis was the saponification of the methyl ester to the acid which would
allow for a functional group susceptible to amide formation.

Scheme 3.19 Synthesis of fully functionalized pyrrole
The saponification proved to be a non trivial reaction which took quite some time to
overcome. The combination of the high steric demand and low solubility of 3-59 made it
impossible to saponify under normal conditions. 3-60 was subjected to various quantities
of 1.7 M NaOH in MeOH and it never fully dissolved or saponified the ester even at
refluxing temperature regardless of how low the concentration of the pyrrole was. Table
3.5 shows the multitude of unsuccessful reactions employed for saponification.
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Table 3.5 Saponification Conditions
Reagent

Solvent

Temperature

Result

1.7 M NaOH (1.2 equiv.)

MeOH

25 °C

Recovery of starting material

1.7 M NaOH (50 equiv.)

MeOH

100 °C

Recovery of starting material

4 M NaOH (50 equiv.)

MeOH:THF

100 °C

Recovery of starting material

C3H9SiOK

DCM

25 °C

Recovery of starting material

* See reference 22.

It was decided that perhaps the saponification at such a late stage is not synthetically the
best route due to the steric demand and lack of solubility of the substrate. Instead amide
formation was attempted prior to the Suzuki coupling. Already aware that the pyrrole was
going to require thermally harsh conditions to undergo saponification it was decided to
start by refluxing 3-58 in copious amounts of MeOH with an equal volume of a 1.7 M
NaOH (100 equiv.) solution (Scheme 3.20). This change in substrate proved effective in
the formation of acid 3-61.

Scheme 3.20 Successful saponification of 3-58
After optimization of the reaction it was determined that the equivalents of NaOH could
be reduced by half while maintaining the same temperature. The reaction also must reflux
for a minimum of 20 hours; anything less would result in the isolation of a mixture of
starting material and product.
The next phase was the formation of the phenyl amide from the carboxcyclic acid. We
opted to initiate the investigation with a DCC coupling; to that vein 3-61 was subjected to
the coupling conditions described in Scheme 3.21.23,24
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Scheme 3.21 DCC coupling
At room temperature only starting material was recovered. The parent acid is sparingly
soluble in Et2O thus in order to dissolve the pyrrole an abundant amount of Et2O was
used. It is possible that the reaction was too dilute and the necessary reagents were not
coming in proper contact to progress the reaction. Sterics is likely also a large factor in
impeding the reaction. To surmount these postulated issues the solvent system was
switched to THF and the reaction was conducted in the same manner but at reflux as seen
in Scheme 3.22.

Scheme 3.22 DCC coupling in refluxing THF
In the above scheme the disappearance of starting material was observed by TLC analysis
and a new significantly more non polar compound was gradually forming. This made us
quite optimistic that the desired product had been formed. But upon isolation of the new
compound it was discovered that product was not produced but instead a compound that
looked like the DCC adduct of the starting material had been created (Figure 3.4). This
conclusion was derived from the 1H NMR spectrum of the isolated compound. It had an
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additional 20 1H’s in the aliphatic region as well as all the characteristic signals of the
substituted pyrrole moiety.
OMe

F

N
O

Br
O

N
HN

3-63

Figure 3.4 DCC adduct of acid
In an attempt to drive the reaction to completion the DCC adduct was dissolved in
toluene and placed in the microwave reactor in the presence of DMAP and excess aniline
in hopes that the extreme thermal conditions and pressure of the microwave would drive
the reaction forward (Scheme 3.23).

Scheme 3.23 DCC coupling under microwave conditions
Microwave heating had no effect on the outcome of the reaction. Again only what was
believed to be the DCC adduct was isolated from the reaction mixture. The apparent lack
of reactivity of 3-61 was attributed to the steric demand of the starting material. At this
point no further reactions with DCC were conducted and CDI couplings were skipped
altogether.
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The substrate required a reactive centre that was not much bulkier if at all then the
carboxylic acid. We chose to examine the possibility of forming the acid chloride in-situ
and then adding in aniline. The acid chloride is not much larger than that of the
carboxylic acid and it is a highly reactive centre. The formation of the amide should
provide a suitable thermodynamic sink to drive the reaction forward. 3-60 was treated
with freshly distilled thionyl chloride in refluxing THF for 4 hours at which time aniline
was added and the reaction continued to reflux for 12 hours according to Scheme 3.24.25
OMe
OMe

F

N
HO2C

2. Aniline, THF
reflux, 12 h

F

N

1. SOCl2, THF,
reflux, 4 h
O

Br
NH

Br
3-61

3-38 (65-86 %)

Scheme 3.24 Amide formation via acid chloride
As it turns out on the first attempt with the two step amide formation 3-38 was
successfully formed in a 65 % yield based on recovered starting material. The uppermost
yield obtained with the reaction was 86 % BRSM however in our hands we could not
continuously reproduce this result. Overall the moderate to excellent yields were quite
satifying with such a sterically encumbered substrate.
The final step was the Suzuki coupling to generate the completed PMP protected Lipitor®
pyrrole. Gratifyingly following the same conditions used previously the Suzuki coupling
was carried out successfully affording the much sought after PMP protected Lipitor®
pyrrole as seen in Scheme 3.25.21
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Scheme 3.25 Completion of the PMP protected pyrrole unit
The complete forward synthesis of the PMP protected pyrrole from the initial
cycloaddition reaction to the final Suzuki coupling can be seen in its entirety, with
respective yields, in Scheme 3.26.

Scheme 3.26 Completed synthesis of PMP protected Lipitor® pyrrole

3.2.6 Attempts at Deprotection and a Formal Synthesis of Lipitor®
With the completed pyrrole moiety only one more step was required to complete a formal
synthesis of Lipitor®. The culmination of the synthesis was the deprotection of the PMP
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group on the nitrogen atom. It has been brought to the attention of the scientific
community, by Jacob Peyton et. al., that a PMP group on an aromatic nitrogen atom can
be readily removed through the use of CAN.26 CAN acts as a mild oxidant converting the
PMP group into a quinone following the general mechanism seen in Figure 3.5.26

Figure 3.5 Mechanism of CAN deprotection
The deptrotection would provide an intermediate which has been previously carried to the
complete molecule; therefore the free N-H pyrrole would provide a formal synthesis of
Lipitor®. According to the literature procedure three equivalents of CAN in a 4:1
CH3CN:H2O solvent mixture will successfully remove a PMP group from a nitrogen
atom in a matter of minutes. Admittedly the first time this experiment was conducted a
slight error was made in the solvent ratio. A ratio of 2:1 was used instead of the reported
4:1; the rest of the conditions matched that of the literature Scheme 3.27.

Scheme 3.27 CAN promoted PMP deprotection
Upon complete consumption of the starting material the reaction was quenched with
NaHCO3 and extracted with Et2O. After obtaining 1H NMR spectrum we were overjoyed
because we believed the deprotection had progressed smoothly and provided a formal
synthesis of Lipitor®. However upon comparison of our 1H NMR spectrum to the
literature spectrum there were two rather obvious inconsistencies. Both the H-N proton
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and the methine iPr proton were significantly upfield according to multiple literature
sources. To emphasize the drastic difference in chemical shift a direct comparison of the
1

H NMR spectra obtained from the experiment and the reported literature respectively

can been seen below (Figure 3.6).27

Figure 3.6 Experimental and literature 1H NMR spectra of the deprotected pyrrole
In order to identify the unknown product it was crystallized by vapour diffusion with
DCM:hexanes. Once the crystallographic data was gathered and solved the result was
completely bewildering. It turns out that CAN had managed to remove the PMP group
then concomitantly cleave the pyrrole ring forming a conjugated 1,4-imine-carbonyl
compound (Scheme 3.28). The crystal structure of the compound produced can be seen in
Figure 3.7.
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Scheme 3.28 Result of CAN deprotection

Figure 3.7 Crystal Structure if 1,4-imine, carbonyl
What was most perplexing about this result was the fact that the imine itself was so stable
that it could be crystallized, let alone survive the aqueous conditions of the reaction and
the workup itself. On the bright side of things however the deprotection did occur. It is
quite possible that the conditions could be controlled or altered in such a way that only
the deprotection and not the ring cleavage will occur. Table 3.6 shows the various
temperature, solvent and equivalencies of CAN employed to effectively remove the PMP
group with CAN.
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Table 3.6 Conditions attempted for CAN deprotection
Equiv. of CAN

Temperature

Solvent

Results

3

RT

CH3CN: H2O (2:1)

Opened Product

2

-30 °C

CH3CN: H2O (4:1)

No reaction

2

0 °C

CH3CN: H2O (4:1)

No reaction

2

RT

CH3CN: H2O (4:1)

No reaction

3

-10 °C

CH3CN: H2O (4:1)

Decomposition

3

0 °C

CH3CN: H2O (4:1)

Decomposition

3

-10 °C

THF: H2O (4:1)

Decomposition

3

0 °C

THF: H2O (4:1)

Decomposition

3

RT

Et2O: H2O (4:1)

Decomposition

3

-10 °C

Et2O: H2O (4:1)

Decomposition

3

0 °C

Et2O: H2O (4:1)

Decomposition

3

RT

DCM: H2O (4:1)

No reaction

A large set of conditions were screened in order to successfully deprotect the nitrogen
atom. In every case upon working up the reaction, dependent upon the temperature, a
mixture of starting material, what appeared to be the open product and decomposition
was formed based on 1H NMR analysis. Not once in any of the 1H NMR spectra gathered
did was the evolution of a septet at approximately 4.11 ppm observed, indicating the
desired product. Obtaining the free nitrogen via this route has proven futile so far.
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A colleague had mentioned a piece of literature that reported the removal of a PMP group
with periodic acid.28 With this information in hand the small amount of material (3-38)
that remained was split into two to test the conditions outlined in the paper. The original
work mentions that the reaction was conducted at room temperature however because of
the lack of solubility of 3-38 under the specific solvent conditions it was predicted
significant heating would be required to drive the reaction at all. As such the described
reaction was carried out at both room temperature and refluxing conditions as seen in
Scheme 3.29.
OMe
F

H
N
F

N

HIO4, H2SO4
CH3CN:H2O( 1:1)

O
NH

RT, O/N

O
NH

3-38

3-63

OMe
F

H
N
F

N

HIO4, H2SO4
CH3CN:H2O( 1:1)

O

reflux, O/N

O

NH

NH

3-38

3-63

Scheme 3.29 Deprotection attempts with periodic acid
Both efforts with periodic acid did not work. In both cases starting material was
recovered and in the first case 3-39 did not dissolve in any appreciable amount, it
remained as a suspension for the entire reaction period. Due to these results no further
reactions with periodic acid.
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3.3 Conclusions
It appears that BM 212 cannot be accessed through the methodology outlined in chapter
2. The inertness of acetaldehyde proved to be far too great a complication to overcome by
simple altering of reaction conditions. It is most likely due to the fact that in the reaction
an iminium species is generated and with the lack of substitution on the aldehyde there is
no adequate donor group capable of stabilizing the partial positive charge on the iminium
carbon.
The core of Atorvastatin Calcium was accessed in comparable steps to that of the
commercial synthesis. The poor yield obtained in the first step of the synthesis is
relatively trivial because sizeable amounts of the inexpensive starting material could be
generated rapidly. Therefore with continuous cycling of starting material through the first
reaction a large stockpile of the necessary tetrahydro-1,2-oxazine could be quickly
synthesized. The remainder of the synthesis albeit is linear but it is difficult to imagine
any other convergent route to this material using our methodology. After formation of the
first pyrrole ring it was simply a matter of altering the corresponding functional groups to
form the drug core. Regrettably however the ring system is far too electron rich to survive
the oxidative PMP deprotections attempted. There are still a few reactions remaining that
could potentially remove the PMP protecting group. One being the use of argentic oxide
in the presence of HNO3, another is a cobalt mediated deprotection in the presence of
t

buOOH and finally perhaps buffering the solution while using CAN will prevent ring

cleavage.29 Another possibility to utilize this work would be to investigate whether or not
the conditions can be altered in such a way that the Tsuji dehydrocarbonylation reaction
can occur with N-akyl substitution not just N-aryl. There still remains an enormous
amount of work that can be done to further improve this methodology and complete the
total synthesis. The outlined synthesis of Lipitor® is likely still viable however a
significant degree of work needs to be carried out in order to fully uncover all the secrets
of the Tsuji dehydrocarbonylation reaction. By fully understanding the reaction itself and
all possible intermediates in the mechanism one could imagine tuning a substrate such
that aliphatic hydroxylamines and nitrones could be used. Due to time constraints
however this work will have to be carried on by a colleague. Nevertheless it is extremely
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important to reiterate that the significance of the tetrahydro-1,2-oxazine to pyrrole
conversion is in the utility to generate such a vast number of different pyrrole systems.

3.4 Experimental Details for Chapter 3
3.4.1

General Considerations

For general considerations refer to section 2.4.1 General Considerations from Chapter 2.
Experimental procedures for cyclopropane synthesis and the one pot conversion of
tetrahydro-1,2-oxazines to pyrrole can be found in sections 2.4.2 and 2.4.5 from Chapter
2 respectively.

3.4.2

Experimental Procedures and Spectroscopic Data for BM
212

Cl

(1R*,2S*)-1-allyl-1-methyl-2-(4-chlorophenyl)cyclopropane-1,1CO2 Me
CO2 allyl

dicarboxylate (3-26): White powder, Rf = 0.47 (30% EtOAc in
hexanes); 1H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 7.13

(d, J = 8.6 Hz, 2H), 5.93 (ddt, J = 17.2, 10.2, 5.5 Hz, 1H), 5.35 (dq, J = 17.2, 1.6 Hz, 1H),
5.26 (dq, J = 10.6, 1.2 Hz, 1H), 4.75-4.62 (m, 2H), 3.42 (s, 3H), 3.20 (t, J = 9.0 Hz, 1H),
2.17 (dd, J = 8.2, 5.5 Hz, 1H), 1.76 (dd, J = 9.0 Hz, 5.1 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ 169.2, 166.8, 133.3, 131.6, 130.0, 128.3, 118.3, 66.2, 52.3, 37.3, 31.7, 19.2;
FT-IR (thin film, cm-1) νmax 2951, 1728, 1496, 1438, 1379, 1332, 1275, 1216, 1179,
1130, 1093, 1016, 983, 934, 837, 772, 713, 541; HRMS calc'd for C15H15ClO4 [M+] =
294.0659 found 294.0662.

NHOH
Cl

N-(4-chlorophenyl)hydroxylamine (3-24): 3-32 (1.0 g, 6.37 mmol) and

Zn dust (1.67 g, 25.40 mmol) were dissolved in CH3CN (25 mL) and sonicated at 25 °C
for 30 minutes. After which time NH4HCO2 (4.01 g, 63.70 mmol) was added in one
portion and the reaction was sonicated for a further 100 minutes. After the allotted
timeframe the reaction was filtered through a Buchner Funnel and the crude material was
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preabsorbed onto silica gel and purified by flash column chromatography (1:10,
EtOAc/hexanes) affording 3-24 as a pale yellow powder (60 %, 0.55 g, 3.82 mmol). The
spectral data matched that of literature data.11

3.4.3

Experimental Procedures and Spectroscopic Data for
Lipitor®

F

(1R*,2S*)-1-allyl-1-methyl-2-(4-F-phenyl)cyclopropane-1,1CO2Me
CO2allyl

dicarboxylate (3-43): Following the general procedure outlined in

Chapter 2 for cyclopropane trans esterification afforded 3-43 as a yellow oil; Rf = 0.48
(30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.18-7.15 (m, 2H), 6.98-6.95 (m,
2H), 5.96-5.87 (m, 1H), 5.35 (app dq, J = 17.2, 1.6 Hz, 1H), 5.26 (app dq, J = 10.6, 1.2
Hz, 1H), 4.76-4.62 (m, 2H), 3.40 (s, 3H), 3.21 (t, J = 9.0 Hz, 1H), 2.16 (dd, J = 8.4, 5.5
Hz, 1H), 1.75 (dd, J = 9.4, 5.5 Hz, 1H);

13

C NMR (100 MHz, CDCl3) δ 169.2, 166.9,

163.3, 160.6, 131.6, 130.2, 130.1, 118.2, 115.2, 115.0, 66.1, 52.2, 37.1, 31.7, 19.2; FT-IR
(thin film, cm-1) νmax 2996, 2952, 2360, 1728, 1608, 1515, 1438, 1379, 1332, 1275, 1217,
1131, 934, 843; HRMS calc’d for C11H10FO2 [M+] 278.0954 found 278.0956.

NHOH
MeO

N-(4-methoxyphenyl)hydroxylamine (3-41): To a suspension of 3-50 (5

g, 33 mmol) and NH4Cl (1.9 g, 36 mmol) in a 1:1 mixture of H2O:EtOH (50 mL) Zn dust
(8 g, 132 mmol) was added portionwise over 15 minutes. After addition was complete the
reaction was allowed to stir for an additional 10 minutes. After the allotted time the
reaction was filtered through a Buchner funnel and 30 mL of brine was added to the

87

filtrate. The filtrate was cooled in an ice salt bath until crystallization was complete and
then filtered again through a Buchner funnel providing 3-43 (2.3 g, 17 mmol, 50 %) as
yellow crystals. The spectral data gathered matched that of the literature data provided.ref

O
O

tert-butylhydroxycarbamate (3-53): BOC-hydroxylamine was synthesized

NHOH

according to the literature procedure.15 To a mixture of hydroxylamine hydrochloride (1.0
g, 14 mmol) in water (15 mL) and DCM (15 mL) at 0 °C was added NaHCO3 (2.2 g, 25
mmol) portionwise. After 10 min di-tbutyldicarbonate (2.5 g, 11 mmol) was added
dropwise. The reaction mixture was allowed to warm to room temperature overnight after
which time the aqueous layer was separated and extracted with DCM (2x 20 mL). The
combined extracts were washed with a saturated NaHCO3 solution (50 mL) and brine (50
mL), dried over MgSO4 and concentrated to afforded 3-52 (67 %, 1.3 g, 9.4 mmol) as a
colourless oil. The spectroscopic data was consistent with that of the literature data.15

MeO
N

O

(E)-4-methoxy-N-(2-methylpropylidene)aniline oxide (3-55): To flask
charged with 3-41 (5 g, 36.00 mmol) 4 Å MS (2 g) and isobutyraldehyde

(10.0 mL, 108.00 mmol) was added anhydrous toluene and then placed under an
atmosphere of Ar. The reaction was allowed to stir for 24 h after which time it was
filtered through a sintered glass funnel. Toluene was removed under reduced pressure and
the remaining residue was dissolved in a minimal amount of hexanes and placed in the
−20 °C freezer. After crystallization was complete the crystals were obtained through
Buchner filtration while washing with cold hexanes affording 3-41 (50 %, 3.74 g, 18.0
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mmol) as orange crystals; Rf = 0.03 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)
δ 7.63-7.57 (m, 2H), 7.00 (d, J = 7.4 Hz, 2H), 6.93-6.87 (m, 2H), 3.83 (s, 3H), 3.36 (m, J
= 6.8, 1H), 1.21 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 160.4, 143.8, 141.0,
122.8, 113.8, 55.5, 26.6, 18.9; FT-IR (thin film, cm-1) νmax 2963, 1598, 1505, 1463, 1254,
1076, 1030, 839, 600; HRMS calc’d for C11H15NO2 [M+] 193.1103 found 193.1096.

MeO

F
N

O

CO2 Me
CO 2allyl

3R,6R)-4-allyl-4-methyl-6-(4-fluorophenyl)-3-isopropyl-2-(4methoxyphenyl)morpholine-4,4-dicarboxylate (3-40): To a

solution of cyclopropane 3-43 (278 mg, 1 mmol) dissolved in 10 mL of anhydrous
toluene with 4 Å MS (200 mg), was added nitrone 3-55 (251 mg, 1.3 mmol) and MgI2
(42 mg, 15 mol%). The reaction was then placed under an atmosphere of Ar and allowed
to stir for 24 hours at room temperature. After filtration and purification (flash column
chromatography, EtOAc/hexanes 1:20) tetrahdyro-1,2-oxazine 3-40 was isolated as a
yellow viscous oil (60 %, 0.60 mmol, 10:1 diastereomeric mixture at C4); Rf = 0.45 (30%
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.45-7.38 (m, 2H), 7.12-7.05 (m, 2H),
7.01-6.95 (m, 2H), 6.83-6.75 (m, 2H), 5.97-5.85 (m, 1H), 5.38-5.30 (m, 1H), 5.30-5.22
(m, 1H), 4.86-4.79 (m, 1H), 4.76-4.65 (m, 2H), 4.59-4.51 (m, 2H), 3.81 (s, 1H), 3.4 (s,
5H), 2.72-2.53 (m, 2H), 2.39 (m, J = 6.6 Hz, 1H), 0.91 (t, J = 6.7 Hz, 3H), 0.87-0.81 (m,
3H);

13

C NMR (100 MHz, CDCl3) δ 170.4, 169.5, 169.4, 168.7, 163.7, 161.3, 153.3,

143.5 (x2), 135.6 (x3), 135.5, 131.6, 131.0, 128.2 (x2), 128.1 (x2), 118.9, 118.8, 115.4,
115.2, 114.2, 114.1 (x3), 67.4, 67.3, 66.6, 66.2, 29.1 (x2), 22.4, 22.2, 22.1; FT-IR (thin
film, cm-1) νmax; HRMS calc’d for C26H30FNO6 [M+] 471.2057 found 471.1987.
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OMe

methyl
F

N

5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-1H-

pyrrole-3-carboxylate (3-39): Following general method B outlined
in Chapter 2 (one-pot procedure), tetrahydro-1,2-oxazine 3-40 (471

MeO 2C

mg, 1 mmol) and Pd2dba3 (55 mg, 6 mol %) were dissolved in CH3CN (5 mL, 80 °C, 3 h)
and refluxed for 3 h. After which time the reaction was cooled to room temperature and
DBU (450 µL, 3 mmol) was added (5 min) affording 3-39 (70 %, 257 mg, 0.70 mmol ) as
a yellow powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.077.03 (m, 2H), 7.02-6.97 (m, 2H), 6.90-6.86 (m, 2H), 6.96-6.80 (m, 2H), 6.73 (s, 1H), 3.84
(s, 3H), 3.83 (s, 3H), 3.10 (m, J = 7.0 Hz, 1H), 1.30 (d, J = 7.0 Hz, 6H); 13C NMR (100
MHz, CDCl3) δ 165.3, 162.8, 160.3, 159.4, 147.5, 132.5, 130.9, 130.1, 130.0, 129.9,
128.7 (x2), 1150, 114.8, 114.2, 111.3, 110.9, 55.4, 50.9, 26.7, 20.4; FT-IR (thin film, cm1

) νmax; 2960, 2275, 1710, 1564, 1513, 1490, 1243, 1222, 1181, 1108, 1043, 840, 780,

544; HRMS calc’d for C22H22FNO3 [M+] 367.1584 found 367.1590.

OMe

methyl-4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4F

N
MeO 2C

Br

methoxyphenyl)-1H-pyrrole-3-carboxylate (3-58): Pyrrole 3-39 (330
mg, 0.90 mmol) was dissolved in DMF (10 mL) and cooled to 0 °C, at

which point NBS (178 mg, 1 mmol) was added in as one portion and the reaction was
allowed to warm to room temperature while stirring for one hour. Upon complete
consumption of the starting material based on TLC analysis 15 mL of H2O was added to
the reaction mixture. The organics were extract 3x with Et2O and then washed with H2O
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and brine. The organic layer was dried over MgSO4 and after filtration and removal of
solvent under reduced pressure pyrrole 3-58 (75 %, 300 mg, 0.63 mmol) was obtained as
a yellow powder; Rf = 0.47 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.137.07 (m, 2H), 6.99-6.95 (m, 2H), 6.91-6.86 (m, 2H), 6.82-6.78 (m, 2H), 3.90 (s, 3H), 3.79
(s, 3H), 3.08 (m, J = 7.0 Hz, 1H), 1.24 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3)
δ 165.1, 163.2, 160.1, 159.4, 145.4, 132.8, 132.7, 131.7, 130.3, 129.9, 126.9, 126.8,
115.0, 114.8, 114.0, 111.6, 97.4, 55.4, 51.1, 27.1, 21.0; FT-IR (thin film, cm-1) νmax 2960,
1708, 1513, 1488, 1243, 1169, 1111, 1044, 842, 732, 540; HRMS calc’d for
C22H21BrFNO3 [M+] 445.0689 found 445.0672.

OMe

Methyl-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-4N
MeO 2C

F

phenyl-1H-pyrrole-3-carboxylate (3-59): 3-58 (100 mg, 0.22 mmol)
was dissolved in degassed DMF (8 mL) and put under an atmosphere

of Ar. At which time PhB(OH)2 (41 mg, 0.34 mmol), Pd(PPh3)4 (10 mol %, 0.022 mmol,
26 mg) and K2CO3 (2M, 0.45 mmol, 220 µL) were added in succession. The reaction was
then heated to 110 °C for 4 hours. After complete consumption of the starting material
based on TLC analysis the reaction was filtered through celite and 10 mL of H2O was
added. The organics were extracted 3x with Et2O and the organic layer was washed with
H2O and brine. After filtration and purification by flash column chromatography
(EtOAc/hexanes, 1:20) compound 3-59 (82 %, 81 mg, 0.18 mmol) was obtained as a
yellow powder; Rf = 0.45 (30% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 7.207.12 (m, 5H), 7.05 (app d, J = 8.6 Hz, 2H), 6.85-6.81 (m, 4H), 6.73-6.67 (app t, J = 9.0
Hz, 2H), 3.80 (s, 3H), 3.13 (m, J = 7.0 Hz, 1H), 1.29 (d, J = 7.0 Hz, 6H); 13C NMR (100
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MHz, CDCl3) δ 167.0, 162.7, 160.2, 159.2, 144.3, 135.6, 133.0, 132.9, 130.7, 130.5,
130.4, 130.2, 127.9 (x2), 127.3, 125.8, 123.7, 114.6, 114.4, 113.9, 111.2, 55.4, 50.8, 26.7,
21.3; FT-IR (thin film, cm-1) νmax; 2960, 2361, 1705, 1512, 1250, 1174, 1242, 846, 733,
700, 544; HRMS calc’d for C28H26FNO3 [M+] 443.1897 found 443.1899.

OMe

F

N

HO 2C

4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-1H-

Br

pyrrole-3-carboxylic acid (3-61): To a flask charged with pyrrole 3-58
(274 mg, 0.61 mmol) was added NaOH (1.7 M, 18 mL, 30.70 mmol)

and an equal volume of MeOH (18 mL). The reaction temperature was increased to 100
°C and allowed to reflux for 20 hours. After which time the reaction was cooled to room
temperature and acidified with 2 M HCl. The organics were extracted 3x with Et2O, the
organic layer was washed with brine and dried over MgSO4. After filtration and flash
column chromatography (EtOAc/hexanes 1:10) pyrrole 3-61 (88 %, 127 mg, 0.29 mmol)
was isolated as clear colourless needles; Rf = 0.22 (30% EtOAc/hexanes); 1H NMR (400
MHz, d6-DMSO) δ 12.42 (s, 1H), 7.22-7.17 (m, 4H), 7.08-7.03 (m, 2H), 6.90-6.88 (m,
2H), 3.72 (s, 3H), 2.98 (m, J = 7.4 Hz, 1H), 1.17 (d, J = 7.0 Hz, 6H);

13

C NMR (100

MHz, d6-DMSO) δ 165.4, 160.2, 159.0, 144.2, 133.2, 133.1, 131.1, 130.3, 129.8, 127.1
(x2), 114.9, 114.7, 114.0, 111.8, 96.8, 55.3, 26.5, 20.7; FT-IR (thin film, cm-1) νmax 2960,
2590, 2361, 1735, 1673, 1513, 1489, 1256, 846, 539; HRMS calc’d for C21H19BrFNO3
[M+] 431.0532 found 431.0530.
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4-bromo-5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-NOMe

phenyl-1H-pyrrole-3-carboxamide (3-38): 3-61 (79 mg, 0.18 mmol)
F

N
O

Br
NH

was dissolved in THF at room temperature and place under an
atmosphere of Ar. Freshly distilled SOCl2 (20 µL, 0.28 mmol) was
added dropwise and the reaction brought to reflux for 4 hours. At this

time the reaction was cooled to room temperature and aniline (33 µL, 0.38 mmol) was
added dropwise. The reaction was brought back to reflux for another 12 hours. Upon
complete consumption of the acid chloride based on TLC analysis the reaction was
cooled to 0 °C and quenched with H2O. The organics were extracted 3x with DCM and
the organic layer was washed with H2O and brine. After filtration and flash column
chromatography (EtOAc/ hexanes 1:20) pyrrole 3-38 (86 % BRSM, 71 mg, 0.14 mmol)
was obtained as a yellow powder; Rf = 0.40 (30% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ 7.90 (s, 1H), 7.68 (app d, J = 7.8 Hz, 2H), 7.38 (app t, J = 7.8 Hz, 2H), 7.167.10 (m, 3H), 7.03-7.00 (m, 2H), 6.93-6.89 (m, 2H), 6.84-6.80 (m, 2H), 3.80 (s, 3H), 3.08
(m, J = 7.0 Hz, 1H), 1.30 (d, J = 7.0 Hz, 6H);

13

C NMR (100 MHz, CDCl3) δ 163.3,

163.1, 160.8, 159.4, 143.5, 138.3, 132.7, 132.6, 130.9, 130.3, 130.0, 129.0, 126.7 (x2),
124.1, 120.0, 116.1, 115.1, 114.9, 114.1, 94.8, 55.4, 27.1, 21.6; FT-IR (thin film, cm-1)
νmax 3415, 2963, 1667, 1596, 1512, 1438, 1248, 1169, 908, 842, 732, 691, 580; HRMS
calc’d for C27H24BrFN2O2 [M+] 506.1005 found 506.1008.
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5-(4-fluorophenyl)-2-isopropyl-1-(4-methoxyphenyl)-N,4-diphenyl-

OMe

F

1H-pyrrole-3-carboxamide (3-37): 3-38 (366 mg, 0.72 mmol) was

N

dissolved in degassed DMF (15 mL) and put under an atmosphere of

O
NH

Ar. At which time PhB(OH)2 (132 mg, 1.08 mmol), Pd(PPh3)4 (10 mol
%, 84 mg, 0.072 mmol) and K2CO3 (2M, 1.44 mmol, 0.72 mL) were added in succession.
The reaction was then heated to 110 °C for 4 hours. After complete consumption of the
starting material based on TLC analysis the reaction was filtered through celite and 10
mL of H2O was added. The organics were extracted 3x with Et2O and the organic layer
was washed with H2O and brine. After filtration and purification by flash column
chromatography (EtOAc/hexanes, 1:20) compound 3-37 (85 %, 312 mg, 0.61 mmol) was
obtained as a yellow powder; Rf = 0.42 (30% EtOAc/hexanes); 1H NMR (400 MHz,
CDCl3) δ 7.27-7.17 (m, 7H), 7.12-7.07 (m, 4H), 7.03-6.97 (m, 1H), 6.95 (s, 1H), 6.906.82 (m, 4H), 6.75-6.68 (m, 2H), 3.81 (s, 3H), 3.22 (m, J = 7.04 Hz, 1H), 1.35 (d, J =
7.04 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 159.2, 183.3, 134.6, 132.9, 132.8, 130.7,
130.7, 130.3, 130.1, 128.7, 128.5, 127.8, 127.8, 126.8, 123.6, 121.4, 119.6, 115.4, 114.7,
114.5, 113.9, 55.4, 26.7, 21.5; FT-IR (thin film, cm-1) νmax 3408, 2931, 2360, 1665, 1594,
1512, 1436, 1250, 1178, 1039, 909, 946, 732; HRMS calc’d for C33H29FN2O2 [M+]
504.2213 found 504.2224.
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Appendix 1: 1H and 13C NMR Spectra for Chapter 2
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